<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm: Arthritis</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest headlines from journals and sites in the Arthritis category.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=arthritis+arthritic&t=Arthritis&f=c&s=Search&r=Any&o=d]]></link>
        <lastBuildDate>Sat, 20 Mar 2010 17:11:13 +0100</lastBuildDate>
        <item>
            <title>Continuous passive motion following total knee arthroplasty in people with arthritis.</title>
            <link>http://www.medworm.com/index.php?rid=3383638&amp;cid=c_1_22_f&amp;fid=38107&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20238330%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The effects of continuous passive motion on knee range of motion are too small to justify its use. There is weak evidence that continuous passive motion reduces the subsequent need for manipulation under anaesthesia.
    PMID: 20238330 [PubMed - in process] (Source: Cochrane Database of Systematic Reviews)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Cochrane Database of Systematic Reviews</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3383638</comments>
            <pubDate>Sat, 20 Mar 2010 06:22:03 +0100</pubDate>
            <guid isPermaLink="false">3383638</guid>        </item>
        <item>
            <title>Arthritis Research UK</title>
            <link>http://www.medworm.com/index.php?rid=3384516&amp;cid=c_1_27_f&amp;fid=35388&amp;url=http%3A%2F%2Fwww.intute.ac.uk%2Fcgi-bin%2Ffullrecord.pl%3Fhandle%3D20100316-16195099</link>
            <description>(formerly known as the Arthritis Research Campaign) is the leading charity in the fight against all forms of arthritis. The charity funds high quality research, educates and informs the public and health professionals on all aspects of the condition, and campaigns for better treatment and support for all those living with arthritis. The website contains a wealth of information including: information on various musculoskeletal conditions, including the different types of arthritis; resources for patients, researchers, allied health professionals, medical students, GPs, and hospital doctors; latest news; videos; and access to 'Arthritis Today' magazine and other publications. (Source: Latest Internet resources added to Intute: Health and LifenSciences nursing gateway)</description>
            <author>Latest Internet resources added to Intute: Health and LifenSciences nursing gateway</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3384516</comments>
            <pubDate>Sat, 20 Mar 2010 03:30:01 +0100</pubDate>
            <guid isPermaLink="false">3384516</guid>        </item>
        <item>
            <title>Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3384871&amp;cid=c_1_49_f&amp;fid=28860&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2796.2010.02226.x</link>
            <description>Conclusion. These findings suggest that it is possible to pharmacologically target the [alpha]7nAChR dependent control of cytokine release in RA patients with suppressed vagus nerve activity. As [alpha]7nAChR agonists ameliorate the clinical course of collagen induced arthritis in animals, it may be possible in the future to explore whether [alpha]7nAChR agonists can improve clinical activity in RA patients. (Source: Journal of Internal Medicine)</description>
            <author>Journal of Internal Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3384871</comments>
            <pubDate>Sat, 20 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3384871</guid>        </item>
        <item>
            <title>Mapping of a standard documentation template to the ICF core sets for arthritis and low back pain</title>
            <link>http://www.medworm.com/index.php?rid=3385102&amp;cid=c_1_66_f&amp;fid=33615&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fpri.466</link>
            <description>Conclusions. The arthritis and LBP Core Sets were reflected in the contents of the template. ICF categories in the Core Sets were reflected in the template (demonstrating up to 55% match). Potential integration of ICF in documentation templates could be explored and examined in the future to enhance clinical encounters and multidisciplinary communication. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: Physiotherapy Research International)</description>
            <author>Physiotherapy Research International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3385102</comments>
            <pubDate>Sat, 20 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3385102</guid>        </item>
        <item>
            <title>Leg Ulceration in Rheumatoid Arthritis  An Underreported Multicausal Complication with Considerable Morbidity: Analysis of Thirty-Six Patients and Review of the Literature</title>
            <link>http://www.medworm.com/index.php?rid=3383975&amp;cid=c_1_6_f&amp;fid=33554&amp;url=http%3A%2F%2Fcontent.karger.com%2Fproduktedb%2Fprodukte.asp%3Fdoi%3D284583</link>
            <description>Dermatology (DOI:10.1159/000284583) (Source: Karger Publishers)</description>
            <author>Karger Publishers</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3383975</comments>
            <pubDate>Fri, 19 Mar 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3383975</guid>        </item>
        <item>
            <title>Ultrasound Guidance Does Not Improve Benefit of Joint Injections for Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3383162&amp;cid=c_1_26_f&amp;fid=36062&amp;url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F718832%3Fsrc%3Drss</link>
            <description>Most joint injections are delivered via clinical examination to guide the injection, but many studies have demonstrated inaccuracy rates of up to 63%, which may contribute to lack of clinical benefit.  Reuters Health Information (Source: Medscape Today Headlines)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Medscape Today Headlines</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3383162</comments>
            <pubDate>Fri, 19 Mar 2010 17:55:27 +0100</pubDate>
            <guid isPermaLink="false">3383162</guid>        </item>
        <item>
            <title>High specificity but low sensitivity of the cartilage oligomeric matrix protein (COMP) test in rheumatoid arthritis and osteoarthritis</title>
            <link>http://www.medworm.com/index.php?rid=3382536&amp;cid=c_1_166_f&amp;fid=33662&amp;url=http%3A%2F%2Fwww.reference-global.com%2Fdoi%2Fabs%2F10.1515%2FCCLM.2010.081</link>
            <description>Clinical Chemistry and Laboratory Medicine 48 (4): 569-570 (Source: Clinical Chemistry and Laboratory Medicine)</description>
            <author>Clinical Chemistry and Laboratory Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3382536</comments>
            <pubDate>Fri, 19 Mar 2010 17:52:47 +0100</pubDate>
            <guid isPermaLink="false">3382536</guid>        </item>
        <item>
            <title>Ultrasound to Treat Chronic Pain</title>
            <link>http://www.medworm.com/index.php?rid=3383531&amp;cid=c_1_26_f&amp;fid=35287&amp;url=http%3A%2F%2Fmedicineworld.org%2Fstories%2Flead%2F3-2010%2Fultrasound-to-treat-chronic-pain.html</link>
            <description>Imagine that after long day tending to patients, a middle-aged nurse feels a burning pain in her knees so intense she can barely walk. For millions of people who suffer from arthritis or other chronic joint pain, this is a familiar story. Right now there are few day-to-day therapies available for these patients, and a number of involve strong medications that can be harmful over time........ (Source: Medicineworld.org: New Article Alert)</description>
            <author>Medicineworld.org: New Article Alert</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3383531</comments>
            <pubDate>Fri, 19 Mar 2010 16:44:09 +0100</pubDate>
            <guid isPermaLink="false">3383531</guid>        </item>
        <item>
            <title>Assessing the functional status and quality of life of patients with rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3381438&amp;cid=c_1_41_f&amp;fid=37453&amp;url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS0482-50042010000100004%26lng%3Den%26nrm%3Diso%26tlng%3Den</link>
            <description>CONCLUSIONS: The study showed that RA is associated with higher disease burden, reflected on pain, impact on global health, and functional and working status, as well as the physical and emotional dimensions of the HRQL. The need for changes in the treatment of this psychologically vulnerable group of patients is paramount. (Source: Revista Brasileira de Reumatologia)</description>
            <author>Revista Brasileira de Reumatologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3381438</comments>
            <pubDate>Fri, 19 Mar 2010 16:37:09 +0100</pubDate>
            <guid isPermaLink="false">3381438</guid>        </item>
        <item>
            <title>The importance of vitamin D levels in autoimmune diseases</title>
            <link>http://www.medworm.com/index.php?rid=3381441&amp;cid=c_1_41_f&amp;fid=37453&amp;url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS0482-50042010000100007%26lng%3Den%26nrm%3Diso%26tlng%3Den</link>
            <description>This article reviews the physiology and immunomodulatory role of vitamin D, emphasizing its involvement in rheumatic diseases such as SLE and RA. (Source: Revista Brasileira de Reumatologia)</description>
            <author>Revista Brasileira de Reumatologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3381441</comments>
            <pubDate>Fri, 19 Mar 2010 16:37:09 +0100</pubDate>
            <guid isPermaLink="false">3381441</guid>        </item>
        <item>
            <title>Lymphadenopathy and systemic lupus erythematosus</title>
            <link>http://www.medworm.com/index.php?rid=3381444&amp;cid=c_1_41_f&amp;fid=37453&amp;url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS0482-50042010000100010%26lng%3Den%26nrm%3Diso%26tlng%3Den</link>
            <description>We report the case of a patient with recurrent episodes of lymphadenopathy associated with hepatosplenomegaly, fever, and weight loss since the age of 13 years. The patient also developed arthritis, hypertension, proteinuria, cardiomyopathy, and peripheral neuropathy. His condition was investigated extensively without diagnostic clarification; he was treated, empirically, for tuberculosis. The patient received a diagnosis of SLE only five years after the original presentation and received the specific treatment. Early diagnosis in those cases is difficult because laboratorial exams may not show the presence of auto-antibodies and low complement levels. (Source: Revista Brasileira de Reumatologia)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Revista Brasileira de Reumatologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3381444</comments>
            <pubDate>Fri, 19 Mar 2010 16:37:09 +0100</pubDate>
            <guid isPermaLink="false">3381444</guid>        </item>
        <item>
            <title>Antibiotic Combos Effective for Chlamydia-Induced Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3381600&amp;cid=c_1_49_f&amp;fid=36063&amp;url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F718826%3Fsrc%3Drss</link>
            <description>Two rifampin-containing antibiotic combos appear to be effective therapy for Chlamydia-induced reactive arthritis, the results of a small study suggest.  Reuters Health Information (Source: Medscape Internal Medicine Headlines)</description>
            <author>Medscape Internal Medicine Headlines</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3381600</comments>
            <pubDate>Fri, 19 Mar 2010 16:22:38 +0100</pubDate>
            <guid isPermaLink="false">3381600</guid>        </item>
        <item>
            <title>RA: Lowering Cardiovascular Risk With Statins</title>
            <link>http://www.medworm.com/index.php?rid=3380155&amp;cid=c_1_7_f&amp;fid=29193&amp;url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F716004%3Fsrc%3Drss</link>
            <description>In patients with rheumatoid arthritis, managing cardiovascular risk is as important as RA-specific therapy.  Nature Reviews Rheumatology (Source: Medscape Cardiology Headlines)</description>
            <author>Medscape Cardiology Headlines</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380155</comments>
            <pubDate>Fri, 19 Mar 2010 12:40:27 +0100</pubDate>
            <guid isPermaLink="false">3380155</guid>        </item>
        <item>
            <title>Opinions of Japanese rheumatology physicians regarding clinical practice guidelines</title>
            <link>http://www.medworm.com/index.php?rid=3381524&amp;cid=c_1_46_f&amp;fid=30995&amp;url=http%3A%2F%2Fintqhc.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F22%2F2%2F78%3Frss%3D1</link>
            <description>Conclusions. Clinical practice guidelines are well accepted among Japanese rheumatology physicians, albeit that the proportion decreased slightly after the introduction of new guidelines. One reason for this may be concern about the use of the guidelines in malpractice litigation. To facilitate implementation, trends in physician support for the guidelines should be closely monitored. (Source: International Journal for Quality in Health Care)</description>
            <author>International Journal for Quality in Health Care</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3381524</comments>
            <pubDate>Fri, 19 Mar 2010 11:24:01 +0100</pubDate>
            <guid isPermaLink="false">3381524</guid>        </item>
        <item>
            <title>Rheumatologists Are Eager To Use Roche-Genentech's ACTEMRA, According To New Study By BioTrends</title>
            <link>http://www.medworm.com/index.php?rid=3380176&amp;cid=c_1_26_f&amp;fid=23292&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2FO5RnXrgrfmo%2F3z9s</link>
            <description>This report is the first in a three wave series and is derived from on-line survey responses from 77 rheumatologists and qualitative interviews with 20 rheumatologists... (Source: Health News from Medical News Today)</description>
            <author>Health News from Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380176</comments>
            <pubDate>Fri, 19 Mar 2010 10:00:00 +0100</pubDate>
            <guid isPermaLink="false">3380176</guid>        </item>
        <item>
            <title>Rheumatologists Are Eager To Use Roche-Genentech's ACTEMRA, According To New Study By BioTrends</title>
            <link>http://www.medworm.com/index.php?rid=3381147&amp;cid=c_1_34_f&amp;fid=22568&amp;url=http%3A%2F%2Fmnt.to%2Ff%2F3z9s</link>
            <description>BioTrends is pleased to announce the publication of a new syndicated report, LaunchTrends®: ACTEMRA. Actemra (tocilizumab), marketed by Roche-Genentech, is the first IL-6 receptor inhibitor agent approved for rheumatoid arthritis... (Source: Pharma Industry News From Medical News Today)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Pharma Industry News From Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3381147</comments>
            <pubDate>Fri, 19 Mar 2010 10:00:00 +0100</pubDate>
            <guid isPermaLink="false">3381147</guid>        </item>
        <item>
            <title>Life stories of people with rheumatoid arthritis who retired early: how gender and other contextual factors shaped their everyday activities, including paid work</title>
            <link>http://www.medworm.com/index.php?rid=3382215&amp;cid=c_1_66_f&amp;fid=33607&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fmsc.168</link>
            <description>Conclusion: Interventions by health professionals in people with RA may benefit from an approach sensitive to personal and environmental factors. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: Musculoskeletal Care)</description>
            <author>Musculoskeletal Care</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3382215</comments>
            <pubDate>Fri, 19 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3382215</guid>        </item>
        <item>
            <title>Characterizing the clinical practice and professional behaviour of rheumatology nurse specialists: a pilot study</title>
            <link>http://www.medworm.com/index.php?rid=3382216&amp;cid=c_1_66_f&amp;fid=33607&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fmsc.173</link>
            <description>Conclusions: We have begun the process of developing a questionnaire that can identify the clinical activities, perceived self-competence and professional behaviour of RNSs. This method of characterizing advanced nursing practice offers potential as a model for nurse specialists in other disciplines. Further work is required to validate the questionnaire on a large cohort of RNSs. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: Musculoskeletal Care)</description>
            <author>Musculoskeletal Care</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3382216</comments>
            <pubDate>Fri, 19 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3382216</guid>        </item>
        <item>
            <title>A literature review regarding the management of varicella-zoster virus</title>
            <link>http://www.medworm.com/index.php?rid=3382217&amp;cid=c_1_66_f&amp;fid=33607&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fmsc.175</link>
            <description>Chickenpox and shingles (varicella-zoster virus [VZV]) pose a threat to individuals who are immunosuppressed and/or have rheumatoid arthritis or another inflammatory musculoskeletal condition. In this paper we present a literature review of the condition, management and prevention. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: Musculoskeletal Care)</description>
            <author>Musculoskeletal Care</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3382217</comments>
            <pubDate>Fri, 19 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3382217</guid>        </item>
        <item>
            <title>Teaching medical students about chronic disease: patient-led teaching in rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3382218&amp;cid=c_1_66_f&amp;fid=33607&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fmsc.169</link>
            <description>Conclusions: We have demonstrated that our patient was at least as good as a doctor at teaching about the impact of chronic disease on patients. Furthermore, this experience is valued by students who appreciate the personal insight that a patient can offer. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: Musculoskeletal Care)</description>
            <author>Musculoskeletal Care</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3382218</comments>
            <pubDate>Fri, 19 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3382218</guid>        </item>
        <item>
            <title>B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B cell maturation antigen-immunoglobulin</title>
            <link>http://www.medworm.com/index.php?rid=3384744&amp;cid=c_1_41_f&amp;fid=29968&amp;url=http%3A%2F%2Farthritis-research.com%2Fcontent%2F12%2F2%2FR48</link>
            <description>Conclusions:
Recombinant BLyS/APRIL heterotrimers have biologic activity and are inhibited by atacicept and BCMA-Ig, but not BAFF-R-Ig. A novel immunoassay demonstrated that native BLyS/APRIL heterotrimers, as well as BLyS and APRIL homotrimers, are elevated in patients with autoimmune diseases. (Source: Arthritis Research and Therapy)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Arthritis Research and Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3384744</comments>
            <pubDate>Fri, 19 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3384744</guid>        </item>
        <item>
            <title>Anticentromere antibody positive Sjogren's Syndrome: a retrospective descriptive analysis</title>
            <link>http://www.medworm.com/index.php?rid=3384745&amp;cid=c_1_41_f&amp;fid=29968&amp;url=http%3A%2F%2Farthritis-research.com%2Fcontent%2F12%2F2%2FR47</link>
            <description>Conclusions:
ACA+/SS has a clinical phenotype intermediate between ACA-/SS and SSc and shows little tendency to evolve to SSc. (Source: Arthritis Research and Therapy)</description>
            <author>Arthritis Research and Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3384745</comments>
            <pubDate>Fri, 19 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3384745</guid>        </item>
        <item>
            <title>Light, Flat Shoes May Be Best for Arthritic Knees</title>
            <link>http://www.medworm.com/index.php?rid=3378917&amp;cid=c_1_26_f&amp;fid=23294&amp;url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F718740%3Fsrc%3Drss</link>
            <description>When it comes to easing the pain of arthritic knees, footwear choice matters, new research shows.  Reuters Health Information (Source: Medscape Medical News Headlines)</description>
            <author>Medscape Medical News Headlines</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3378917</comments>
            <pubDate>Thu, 18 Mar 2010 17:52:17 +0100</pubDate>
            <guid isPermaLink="false">3378917</guid>        </item>
        <item>
            <title>The Discovery of Novel Experimental Therapies for Inflammatory Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3377651&amp;cid=c_1_60_f&amp;fid=37035&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fmi%2F2009%2F698769.html</link>
            <description>Conventional and biologic disease-modifying antirheumatic drugs have revolutionized the medical therapy of inflammatory arthritis. However, it remains unclear as to what can be done to treat immune-mediated chronic inflammation after patients become refractory to these therapies or develop serious side-effects and/or infections forcing drug withdrawal. Because of these concerns it is imperative that novel targets be continuously identified and experimental strategies designed to test potential arthritis interventions in vitro, but more importantly, in well-validated animal models of inflammatory arthritis. Over the past few years, sphingosine-1-phosphate, interleukin-7 receptor, spleen tyrosine kinase, extracellular signal-regulated kinase, mitogen-activated protein kinase 5/p38 kinase reg...</description>
            <author>Mediators of Inflammation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3377651</comments>
            <pubDate>Thu, 18 Mar 2010 16:18:55 +0100</pubDate>
            <guid isPermaLink="false">3377651</guid>        </item>
        <item>
            <title>PI3K p110{delta} regulates T-cell cytokine production during primary and secondary immune responses in mice and humans</title>
            <link>http://www.medworm.com/index.php?rid=3380579&amp;cid=c_1_19_f&amp;fid=29474&amp;url=http%3A%2F%2Fbloodjournal.hematologylibrary.org%2Fcgi%2Fcontent%2Fshort%2F115%2F11%2F2203%3Frss%3D1</link>
            <description>In this study, using the isoform-selective inhibitor IC87114, we show that sustained p110 activity is required for interferon- production. Moreover, acute inhibition of p110 inhibits cytokine production and reduces hypersensitivity responses in mice. Whether p110 played a similar role in human T cells was unknown. Here we show that IC87114 potently blocked T-cell receptor&amp;ndash;induced phosphoinositide 3-kinase signaling by both naive and effector/memory human T cells. Importantly, IC87114 reduced cytokine production by memory T cells from healthy and allergic donors and from inflammatory arthritis patients. These studies establish that previously activated memory T cells are at least as sensitive to p110 inhibition as naive T cells and show that mouse models accurately predict p110 functi...</description>
            <author>Blood</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380579</comments>
            <pubDate>Thu, 18 Mar 2010 16:02:03 +0100</pubDate>
            <guid isPermaLink="false">3380579</guid>        </item>
        <item>
            <title>Muscle Cramps</title>
            <link>http://www.medworm.com/index.php?rid=3381433&amp;cid=c_1_41_f&amp;fid=29977&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D2024%26k%3DArthritis_General</link>
            <description>Title: Muscle CrampsCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 3/18/2010 (Source: MedicineNet Arthritis General)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>MedicineNet Arthritis General</author>
            <type>consumer</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3381433</comments>
            <pubDate>Thu, 18 Mar 2010 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">3381433</guid>        </item>
        <item>
            <title>Brief Meditation Training Brings Pain Relief</title>
            <link>http://www.medworm.com/index.php?rid=3381434&amp;cid=c_1_41_f&amp;fid=29977&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D114519%26k%3DArthritis_General</link>
            <description>Title: Brief Meditation Training Brings Pain ReliefCategory: Health NewsCreated: 3/17/2010 4:45:00 PMLast Editorial Review: 3/18/2010 (Source: MedicineNet Arthritis General)</description>
            <author>MedicineNet Arthritis General</author>
            <type>consumer</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3381434</comments>
            <pubDate>Thu, 18 Mar 2010 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">3381434</guid>        </item>
        <item>
            <title>Slit3 inhibits Robo3-induced invasion of synovial fibroblasts in rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3376876&amp;cid=c_1_41_f&amp;fid=29968&amp;url=http%3A%2F%2Farthritis-research.com%2Fcontent%2F12%2F2%2FR45</link>
            <description>Conclusions:
Taken together, our data showed that deregulation of the Robo3 receptor in synovial fibroblasts in RA correlates with aggressiveness of the fibroblasts. Slit3 reduces the migratory activity of synovial cells from patients with RA, potentially by repulsion of the cells in analogy to the neuronal system. Further studies will be necessary to prove Slit activity in vivo. (Source: Arthritis Research and Therapy)</description>
            <author>Arthritis Research and Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376876</comments>
            <pubDate>Thu, 18 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3376876</guid>        </item>
        <item>
            <title>Development of proteoglycan-induced arthritis depends on T cell-supported autoantibody production, but does not involve significant influx of T cells into the joints</title>
            <link>http://www.medworm.com/index.php?rid=3376877&amp;cid=c_1_41_f&amp;fid=29968&amp;url=http%3A%2F%2Farthritis-research.com%2Fcontent%2F12%2F2%2FR44</link>
            <description>Conclusions:
Our results suggest that antigen-specific T cells, which home to lymphoid organs and provide help to B cells for systemic autoantibody production, play a greater role in the development and progression of autoimmune arthritis than the small population of T cells that migrate to the joints. (Source: Arthritis Research and Therapy)</description>
            <author>Arthritis Research and Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376877</comments>
            <pubDate>Thu, 18 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3376877</guid>        </item>
        <item>
            <title>Vasculogenesis in rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3376879&amp;cid=c_1_41_f&amp;fid=29968&amp;url=http%3A%2F%2Farthritis-research.com%2Fcontent%2F12%2F2%2F110</link>
            <description>Decreased number and impaired functions of endothelial progenitor cells (EPCs) leading to impaired vasculogenesis have been associated with rheumatoid arthritis (RA). Defective vasculogenesis has also been implicated in premature atherosclerosis in RA. Recently, early outgrowth, monocytic and late outgrowth, hemangioblastic EPC subsets have been characterized. Hemangioblastic EPCs may exert increased numbers in active RA and may play a role in vascular repair underlying RA. (Source: Arthritis Research and Therapy)</description>
            <author>Arthritis Research and Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376879</comments>
            <pubDate>Thu, 18 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3376879</guid>        </item>
        <item>
            <title>Limited educational attainment and radiographic and symptomatic knee osteoarthritis: a cross-sectional analysis using data from the Johnston County (North Carolina) Osteoarthritis Project</title>
            <link>http://www.medworm.com/index.php?rid=3381428&amp;cid=c_1_41_f&amp;fid=29968&amp;url=http%3A%2F%2Farthritis-research.com%2Fcontent%2F12%2F2%2FR46</link>
            <description>IntroductionApplying a cross-sectional analysis to a sample of 2627 African American and Caucasian adults aged [greater than or equal to]45 years from the Johnston County Osteoarthritis Project, we studied the association between educational attainment and prevalence of radiographic knee osteoarthritis and symptomatic knee osteoarthritis.
Methods:
Age- and race-adjusted associations between education and osteoarthritis outcomes were assessed by gender-stratified logistic regression models, with additional models adjusting for body mass index, knee injury, smoking, alcohol use, and occupational factors.
Results:
In an analysis of all participants, low educational attainment ( (Source: Arthritis Research and Therapy)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Arthritis Research and Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3381428</comments>
            <pubDate>Thu, 18 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3381428</guid>        </item>
        <item>
            <title>Fc &amp;#x03B3; R IIIB polymorphisms: their association with clinical manifestations and autoantibodies in SLE patients from Western India</title>
            <link>http://www.medworm.com/index.php?rid=3381430&amp;cid=c_1_41_f&amp;fid=29971&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1756-185X.2010.01469.x</link>
            <description>Conclusion: Among SLE patients studied, NA2 was the prominent allele. It was commonly associated with clinical manifestations such as skin rash, arthritis, hematological and immunological disorders. This suggests that the primary involvement of Fc [gamma] R IIIB NA2 allele is more likely involved with disease susceptibility of SLE. (Source: APLAR Journal of Rheumatology)</description>
            <author>APLAR Journal of Rheumatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3381430</comments>
            <pubDate>Thu, 18 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3381430</guid>        </item>
        <item>
            <title>Miliary tuberculosis and necrotizing tuberculous fasciitis &amp;#x2013; An unusual coexistence in a rheumatoid arthritis patient</title>
            <link>http://www.medworm.com/index.php?rid=3381432&amp;cid=c_1_41_f&amp;fid=29971&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1756-185X.2010.01467.x</link>
            <description>We report a case of a 65-year-old Korean female patient with rheumatoid arthritis, who presented with extensive necrotizing fasciitis of the gluteus muscles, as an unusual initial manifestation of miliary tuberculosis. The patient had been previously treated with conventional disease-modifying antirheumatic drugs and low-dose steroids for 7 years. However, she recently developed fever, warmth and painful swelling in her right buttock. Magnetic resonance imaging indicated necrotizing fasciitis of the gluteus muscles and a fasciectomy specimen revealed a Mycobacterium tuberculosis infection. Two weeks after a fasciectomy, miliary tuberculosis of the lung was diagnosed by high resolution chest computed tomography. Soft tissue infection due to M. tuberculosis should be included as a differenti...</description>
            <author>APLAR Journal of Rheumatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3381432</comments>
            <pubDate>Thu, 18 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3381432</guid>        </item>
        <item>
            <title>Acute non-traumatic hip pathology in children: incidence and presentation in family practice</title>
            <link>http://www.medworm.com/index.php?rid=3376486&amp;cid=c_1_35_f&amp;fid=28826&amp;url=http%3A%2F%2Ffampra.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F2%2F166%3Frss%3D1</link>
            <description>Conclusion. In family practice, most children with acute non-traumatic hip pathology present with pain as the initial symptom. FPs need to be more aware that fever is the main distinguishing factor between a harmless condition and a life-threatening condition. Transient synovitis is the diagnosis with the highest incidence rate. (Source: Family Practice)</description>
            <author>Family Practice</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376486</comments>
            <pubDate>Wed, 17 Mar 2010 21:41:56 +0100</pubDate>
            <guid isPermaLink="false">3376486</guid>        </item>
        <item>
            <title>Rheumatoid arthritis tied to pregnancy complications</title>
            <link>http://www.medworm.com/index.php?rid=3374529&amp;cid=c_1_26_f&amp;fid=23271&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Freuters%2FhealthNews%2F%7E3%2F9n2fr7K-iV0%2FidUSTRE62G44W20100317</link>
            <description>NEW YORK (Reuters Health) - Pregnant women with rheumatoid arthritis may have increased risks of high blood pressure, having an underweight baby or needing a cesarean section, a new study suggests. (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3374529</comments>
            <pubDate>Wed, 17 Mar 2010 19:13:34 +0100</pubDate>
            <guid isPermaLink="false">3374529</guid>        </item>
        <item>
            <title>Light, flat shoes may be best for arthritic knees</title>
            <link>http://www.medworm.com/index.php?rid=3374530&amp;cid=c_1_26_f&amp;fid=23271&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Freuters%2FhealthNews%2F%7E3%2Fnn8RQUNentY%2FidUSTRE62G41C20100317</link>
            <description>NEW YORK (Reuters Health) - When it comes to easing the pain of arthritic knees, footwear choice matters, new research shows. (Source: Reuters: Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reuters: Health</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3374530</comments>
            <pubDate>Wed, 17 Mar 2010 18:58:07 +0100</pubDate>
            <guid isPermaLink="false">3374530</guid>        </item>
        <item>
            <title>Rituximab Promising in IgG4-Related Diseases</title>
            <link>http://www.medworm.com/index.php?rid=3376883&amp;cid=c_1_41_f&amp;fid=29980&amp;url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F718592%3Fsrc%3Drss</link>
            <description>A small study of patients with refractory IgG4-related systemic disease showed prompt improvement with rituximab (Rituxan and MabThera), researchers report in a February 26th online paper in Arthritis and Rheumatism.  Reuters Health Information (Source: Medscape Rheumatology Headlines)</description>
            <author>Medscape Rheumatology Headlines</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376883</comments>
            <pubDate>Wed, 17 Mar 2010 18:09:53 +0100</pubDate>
            <guid isPermaLink="false">3376883</guid>        </item>
        <item>
            <title>Anti-Inflammatory Effects of Licorice and Roasted Licorice Extracts on TPA-Induced Acute Inflammation and Collagen-Induced Arthritis in Mice</title>
            <link>http://www.medworm.com/index.php?rid=3373704&amp;cid=c_1_70_f&amp;fid=37047&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fjbb%2F2010%2F709378.html</link>
            <description>The anti-inflammatory activity of licorice (LE) and roated licorice (rLE) extracts determined in the murine phorbol ester-induced acute inflammation model and collagen-induced arthritis (CIA) model of human rheumatoid arthritis. rLE possessed greater activity than LE in inhibiting phorbol ester-induced ear edema. Oral administration of LE or rLE reduced clinical arthritis score, paw swelling, and histopathological changes in a murine CIA. LE and rLE decreased the levels of proinflammatory cytokines in serum and matrix metalloproteinase-3 expression in the joints. Cell proliferation and cytokine secretion in response to type II collagen or lipopolysaccharide stimulation were suppressed in spleen cells from LE or rLE-treated CIA mice. Furthermore, LE and rLE treatment prevented oxidative dam...</description>
            <author>Journal of Biomedicine and Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3373704</comments>
            <pubDate>Wed, 17 Mar 2010 16:37:28 +0100</pubDate>
            <guid isPermaLink="false">3373704</guid>        </item>
        <item>
            <title>A Possible Role for Epigenetics in Age-Dependent Bone Diseases</title>
            <link>http://www.medworm.com/index.php?rid=3381593&amp;cid=c_1_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F66005650167247g4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Epigenetics, the study of changes in gene expression without alteration of the DNA sequence, has emerged as a promising area
 of research in the field of age-related diseases. Epigenetic processes, mainly DNA methylation and histone acetylation, can
 influence genotypes as a response to environmental and stochastic factors. The aging process is considered to be an accumulation
 of molecular errors, which also affect epigenetic mechanisms and could contribute to the appearance of age-related diseases.
 Based on the role of epigenetics in several age-dependent diseases, in this paper we discuss its possible involvement in age-dependent
 bone diseases such as osteoporosis and rheumatoid arthritis.
 
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12018-0...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3381593</comments>
            <pubDate>Wed, 17 Mar 2010 15:51:42 +0100</pubDate>
            <guid isPermaLink="false">3381593</guid>        </item>
        <item>
            <title>iTRAQ-based proteomic identification of leucine-rich {alpha}-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases</title>
            <link>http://www.medworm.com/index.php?rid=3376870&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F770%3Frss%3D1</link>
            <description>Conclusions
LRG represents a novel serum biomarker for monitoring disease activity during therapy in autoimmune patients, particularly useful in patients with active disease but normal CRP levels. (Source: Annals of the Rheumatic Diseases)</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376870</comments>
            <pubDate>Wed, 17 Mar 2010 14:46:00 +0100</pubDate>
            <guid isPermaLink="false">3376870</guid>        </item>
        <item>
            <title>Lipoma arborescens co-existing with psoriatic arthritis releases tumour necrosis factor alpha and matrix metalloproteinase 3</title>
            <link>http://www.medworm.com/index.php?rid=3376872&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F776%3Frss%3D1</link>
            <description>(Source: Annals of the Rheumatic Diseases)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376872</comments>
            <pubDate>Wed, 17 Mar 2010 14:46:00 +0100</pubDate>
            <guid isPermaLink="false">3376872</guid>        </item>
        <item>
            <title>Synovial tissue and serum biomarkers of disease activity, therapeutic response and radiographic progression: analysis of a proof-of-concept randomised clinical trial of cytokine blockade</title>
            <link>http://www.medworm.com/index.php?rid=3376855&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F706%3Frss%3D1</link>
            <description>Conclusions
Synovial tissue analysis identified biomarkers of disease activity, therapeutic response and radiographic progression. Biomarker expression in tissue was independent of the levels measured in the serum. (Source: Annals of the Rheumatic Diseases)</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376855</comments>
            <pubDate>Wed, 17 Mar 2010 14:45:59 +0100</pubDate>
            <guid isPermaLink="false">3376855</guid>        </item>
        <item>
            <title>Increased risk of adverse pregnancy outcomes in women with rheumatoid arthritis: a nationwide population-based study</title>
            <link>http://www.medworm.com/index.php?rid=3376857&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F715%3Frss%3D1</link>
            <description>Conclusion
Women with RA had an increased risk of LBW, SGA babies, preeclampsia and CS compared with unaffected women. (Source: Annals of the Rheumatic Diseases)</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376857</comments>
            <pubDate>Wed, 17 Mar 2010 14:45:59 +0100</pubDate>
            <guid isPermaLink="false">3376857</guid>        </item>
        <item>
            <title>Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension</title>
            <link>http://www.medworm.com/index.php?rid=3376858&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F718%3Frss%3D1</link>
            <description>Conclusions
In the limited population of JRA patients remaining in the study at 4 years, infliximab was safe and effective but associated with a high patient discontinuation rate.
Clinical trials registration number NCT00036374. (Source: Annals of the Rheumatic Diseases)</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376858</comments>
            <pubDate>Wed, 17 Mar 2010 14:45:59 +0100</pubDate>
            <guid isPermaLink="false">3376858</guid>        </item>
        <item>
            <title>CARD8 p.C10X polymorphism is associated with inflammatory activity in early rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3376859&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F723%3Frss%3D1</link>
            <description>Conclusions
Carriage of CARD8-X is associated with a worse disease course in early RA. (Source: Annals of the Rheumatic Diseases)</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376859</comments>
            <pubDate>Wed, 17 Mar 2010 14:45:59 +0100</pubDate>
            <guid isPermaLink="false">3376859</guid>        </item>
        <item>
            <title>Repair of joint erosions in rheumatoid arthritis: prevalence and patient characteristics in a large inception cohort</title>
            <link>http://www.medworm.com/index.php?rid=3376860&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F727%3Frss%3D1</link>
            <description>Conclusions
Repair occurred in 7.2% of the patients with RA, particularly in clinically inactive joints in patients with severe destructive disease. (Source: Annals of the Rheumatic Diseases)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376860</comments>
            <pubDate>Wed, 17 Mar 2010 14:45:59 +0100</pubDate>
            <guid isPermaLink="false">3376860</guid>        </item>
        <item>
            <title>Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3376861&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F730%3Frss%3D1</link>
            <description>Conclusion
The diagnostic performance of the anti-MCV test in the differential diagnosis of early arthritis is lower than that of the anti-CCP tests. (Source: Annals of the Rheumatic Diseases)</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376861</comments>
            <pubDate>Wed, 17 Mar 2010 14:45:59 +0100</pubDate>
            <guid isPermaLink="false">3376861</guid>        </item>
        <item>
            <title>Association of an ERAP1 ERAP2 haplotype with familial ankylosing spondylitis</title>
            <link>http://www.medworm.com/index.php?rid=3376863&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F733%3Frss%3D1</link>
            <description>Conclusion
This study shows that one ERAP1 SNP and a haplotype in the ERAP1 and ERAP2 locus are associated with familial AS. (Source: Annals of the Rheumatic Diseases)</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376863</comments>
            <pubDate>Wed, 17 Mar 2010 14:45:59 +0100</pubDate>
            <guid isPermaLink="false">3376863</guid>        </item>
        <item>
            <title>Overproduced interleukin 6 decreases blood lipid levels via upregulation of very-low-density lipoprotein receptor</title>
            <link>http://www.medworm.com/index.php?rid=3376865&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F741%3Frss%3D1</link>
            <description>Conclusions
Overproduced IL6 decreased blood lipid levels by increasing VLDLR expression in several tissues. It is concluded that IL6 blockade normalises reduced lipid levels caused by IL6, but does not affect normal lipid metabolism. (Source: Annals of the Rheumatic Diseases)</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376865</comments>
            <pubDate>Wed, 17 Mar 2010 14:45:59 +0100</pubDate>
            <guid isPermaLink="false">3376865</guid>        </item>
        <item>
            <title>FoxO3a involved in neutrophil and T cell survival is overexpressed in rheumatoid blood and synovial tissue</title>
            <link>http://www.medworm.com/index.php?rid=3376867&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F755%3Frss%3D1</link>
            <description>Conclusion
The overexpression of FoxO3a in blood from patients with RA, particularly in PMNs, suggests a potential role for this gene in the pathogenesis of RA through increased survival of blood PMNs. In synovium from patients with RA, FoxO3a mainly detected in inflammatory aggregates may also regulate the chronic survival of T lymphocytes. (Source: Annals of the Rheumatic Diseases)</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376867</comments>
            <pubDate>Wed, 17 Mar 2010 14:45:59 +0100</pubDate>
            <guid isPermaLink="false">3376867</guid>        </item>
        <item>
            <title>PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population</title>
            <link>http://www.medworm.com/index.php?rid=3376847&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F666%3Frss%3D1</link>
            <description>Conclusion
In the largest study performed to date, the PADI4 genotype was not a significant risk factor for RA in people of European ancestry, in contrast to Asian populations. (Source: Annals of the Rheumatic Diseases)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376847</comments>
            <pubDate>Wed, 17 Mar 2010 14:45:58 +0100</pubDate>
            <guid isPermaLink="false">3376847</guid>        </item>
        <item>
            <title>Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3376848&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F671%3Frss%3D1</link>
            <description>Conclusion
In this real-life study, MTX treatment was associated with improvement in disease activity and health-related quality of life in patients with PsA after 6 months of treatment. Retention rates of MTX were similar in PsA and RA. (Source: Annals of the Rheumatic Diseases)</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376848</comments>
            <pubDate>Wed, 17 Mar 2010 14:45:58 +0100</pubDate>
            <guid isPermaLink="false">3376848</guid>        </item>
        <item>
            <title>Is shift work a risk factor for rheumatoid arthritis? The Finnish Public Sector study</title>
            <link>http://www.medworm.com/index.php?rid=3376850&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F679%3Frss%3D1</link>
            <description>(Source: Annals of the Rheumatic Diseases)</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376850</comments>
            <pubDate>Wed, 17 Mar 2010 14:45:58 +0100</pubDate>
            <guid isPermaLink="false">3376850</guid>        </item>
        <item>
            <title>Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?</title>
            <link>http://www.medworm.com/index.php?rid=3376851&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F683%3Frss%3D1</link>
            <description>Conclusions
Depending on the risk stratification method, 2% to 26% of patients with RA without CVD have sufficiently high risk to require statin therapy, yet most of them remain untreated. To address this issue, we would recommend annual systematic screening using the nationally applicable risk calculator, combined with regular audit of whether treatment targets have been achieved. (Source: Annals of the Rheumatic Diseases)</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376851</comments>
            <pubDate>Wed, 17 Mar 2010 14:45:58 +0100</pubDate>
            <guid isPermaLink="false">3376851</guid>        </item>
        <item>
            <title>The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases</title>
            <link>http://www.medworm.com/index.php?rid=3376853&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F696%3Frss%3D1</link>
            <description>Conclusion
A significant association was found for the TRAF1-C5 locus in SLE, implying that this region lies in a pathway relevant to multiple autoimmune diseases. (Source: Annals of the Rheumatic Diseases)</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376853</comments>
            <pubDate>Wed, 17 Mar 2010 14:45:58 +0100</pubDate>
            <guid isPermaLink="false">3376853</guid>        </item>
        <item>
            <title>Genetic variants of STAT4 associated with rheumatoid arthritis in persons of Asian and European ancestry do not replicate in African Americans</title>
            <link>http://www.medworm.com/index.php?rid=3376839&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F625%3Frss%3D1</link>
            <description>(Source: Annals of the Rheumatic Diseases)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376839</comments>
            <pubDate>Wed, 17 Mar 2010 14:45:57 +0100</pubDate>
            <guid isPermaLink="false">3376839</guid>        </item>
        <item>
            <title>'Treat to target': moving targets from hypertension, hyperlipidaemia and diabetes to rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3376840&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F629%3Frss%3D1</link>
            <description>(Source: Annals of the Rheumatic Diseases)</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376840</comments>
            <pubDate>Wed, 17 Mar 2010 14:45:57 +0100</pubDate>
            <guid isPermaLink="false">3376840</guid>        </item>
        <item>
            <title>Treating rheumatoid arthritis to target: recommendations of an international task force</title>
            <link>http://www.medworm.com/index.php?rid=3376841&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F631%3Frss%3D1</link>
            <description>Conclusion
The 10 recommendations are supposed to inform patients, rheumatologists and other stakeholders about strategies to reach optimal outcomes of RA based on evidence and expert opinion. (Source: Annals of the Rheumatic Diseases)</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376841</comments>
            <pubDate>Wed, 17 Mar 2010 14:45:57 +0100</pubDate>
            <guid isPermaLink="false">3376841</guid>        </item>
        <item>
            <title>Evidence for treating rheumatoid arthritis to target: results of a systematic literature search</title>
            <link>http://www.medworm.com/index.php?rid=3376842&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F638%3Frss%3D1</link>
            <description>Conclusion
Only few studies employed randomised controlled settings to test the value of treatment to a specific target. However, they provided unanimous evidence for benefits of targeted approaches. Nevertheless, more data on radiographic and functional outcomes and on patients with established RA are needed. (Source: Annals of the Rheumatic Diseases)</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376842</comments>
            <pubDate>Wed, 17 Mar 2010 14:45:57 +0100</pubDate>
            <guid isPermaLink="false">3376842</guid>        </item>
        <item>
            <title>Assessment of active spinal inflammatory changes in patients with axial spondyloarthritis: validation of whole body MRI against conventional MRI</title>
            <link>http://www.medworm.com/index.php?rid=3376844&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F648%3Frss%3D1</link>
            <description>Conclusion
WB MRI and CON MRI scores showed a high correlation and comparable high reliability for the detection of active inflammatory lesions in the spine of patients with clinically active SpA. (Source: Annals of the Rheumatic Diseases)</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376844</comments>
            <pubDate>Wed, 17 Mar 2010 14:45:57 +0100</pubDate>
            <guid isPermaLink="false">3376844</guid>        </item>
        <item>
            <title>Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case-control study</title>
            <link>http://www.medworm.com/index.php?rid=3376845&amp;cid=c_1_41_f&amp;fid=29967&amp;url=http%3A%2F%2Fard.bmj.com%2Fcgi%2Fcontent%2Fshort%2F69%2F4%2F654%3Frss%3D1</link>
            <description>Conclusion
In this RA population, use of steroids was associated with reduced lymphoma risk. Whether this association is a generic effect of steroids or specific to the studied population remains unknown. (Source: Annals of the Rheumatic Diseases)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Annals of the Rheumatic Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376845</comments>
            <pubDate>Wed, 17 Mar 2010 14:45:57 +0100</pubDate>
            <guid isPermaLink="false">3376845</guid>        </item>
        <item>
            <title>Menopause</title>
            <link>http://www.medworm.com/index.php?rid=3376882&amp;cid=c_1_41_f&amp;fid=29977&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D2036%26k%3DArthritis_General</link>
            <description>Title: MenopauseCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 3/17/2010 (Source: MedicineNet Arthritis General)</description>
            <author>MedicineNet Arthritis General</author>
            <type>consumer</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376882</comments>
            <pubDate>Wed, 17 Mar 2010 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">3376882</guid>        </item>
        <item>
            <title>ACTEMRA(tocilizumab) filed in the US for Prevention of Structural Joint Damage and Improvement of Physical Function in Rheumatoid Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3372420&amp;cid=c_1_34_f&amp;fid=37969&amp;url=http%3A%2F%2Fwww.roche.com%2Finvestors%2Fir_update%2Finv-update-2010-03-17.htm</link>
            <description>Roche announced today that it has submitted a supplemental Biologics License Application (sBLA) to the United States (US) Food and Drug Administration (FDA) for ACTEMRA (tocilizumab, RoACTEMRA in the European Union) for the prevention of structural joint damage and to improve physical function in adults with moderately to severe active rheumatoid arthritis (RA). ACTEMRA was approved by the FDA on January 8, 2010 as the first interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody to treat RA in adult patients after an inadequate response to at least one other medicine called a tumor necrosis factor (TNF) antagonist. (Source: Roche Investor Update)</description>
            <author>Roche Investor Update</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3372420</comments>
            <pubDate>Wed, 17 Mar 2010 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">3372420</guid>        </item>
        <item>
            <title>Genentech Submits Supplemental Biologics License Application for ACTEMRA(R) (tocilizumab) for Prevention of Structural Joint Damage and Improvement of Physical Function in Rheumatoid Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3372393&amp;cid=c_1_34_f&amp;fid=35575&amp;url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2030383</link>
            <description>SOUTH SAN FRANCISCO, Calif.--(HSMN NewsFeed)--Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug A... Biopharmaceuticals, FDAGenentech, Roche Group, ACTEMRA, tocilizumab, rheumatoid arthritis, LITHE trial (Source: HSMN NewsFeed)</description>
            <author>HSMN NewsFeed</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3372393</comments>
            <pubDate>Wed, 17 Mar 2010 02:17:34 +0100</pubDate>
            <guid isPermaLink="false">3372393</guid>        </item>
        <item>
            <title>Development of a self-administered early inflammatory arthritis detection tool</title>
            <link>http://www.medworm.com/index.php?rid=3376306&amp;cid=c_1_31_f&amp;fid=29524&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1471-2474%2F11%2F50</link>
            <description>Conclusions:
An eleven-question, EIA detection tool suitable for self-administration was developed to screen subjects with six to 52 weeks of musculoskeletal complaints. Psychometric and performance property testing of the tool is ongoing. (Source: BMC Musculoskeletal Disorders)</description>
            <author>BMC Musculoskeletal Disorders</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3376306</comments>
            <pubDate>Wed, 17 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3376306</guid>        </item>
        <item>
            <title>Arthritis Drug Salsalate in Clinical Trials for Type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=3378005&amp;cid=c_1_91_f&amp;fid=33026&amp;url=http%3A%2F%2Fdiabetes.about.com%2Fb%2F2010%2F03%2F17%2Farthritis-drug-salsalate-in-clinical-trials-for-type-2-diabetes.htm</link>
            <description>According to a press release from Joslin Diabetes Center, the arthritis drug, salsalate proved to lower blood glucose levels significantly. In the study, salsalate lowered A1c levels by 0.5%, as well as lowering triglycerides and raising a protein that appears to benefit cardiac health.

&quot;These results are exciting,&quot; says Allison Goldfine, M.D., Joslin's Director of Clinical Research and an Associate Professor at Harvard Medical School. &quot;They indicate that salsalate may provide an effective, safe and inexpensive new avenue for diabetes treatment.&quot;

Dr. Goldfine goes on to say that although the drug looks promising for treating type 2 diabetes, clinical trials are still ongoing. Scientists involved in the study recommend that patients do not use this medication for their diabetes until fur...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>About Diabetes</author>
            <type>consumer</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3378005</comments>
            <pubDate>Wed, 17 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3378005</guid>        </item>
        <item>
            <title>Old Arthritis Drug May Help Diabetics (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3369102&amp;cid=c_1_47_f&amp;fid=32588&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FPrimaryCare%2FDiabetes%2F19051</link>
            <description>A drug widely used to treat joint pain improved blood glucose control in patients with type 2 diabetes, researchers said. (Source: MedPage Today Nephrology)</description>
            <author>MedPage Today Nephrology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3369102</comments>
            <pubDate>Tue, 16 Mar 2010 17:13:08 +0100</pubDate>
            <guid isPermaLink="false">3369102</guid>        </item>
        <item>
            <title>Viron Reports Positive Proof of Concept Results in Arthritis for its VT-346 anti-TNF Therapeutic</title>
            <link>http://www.medworm.com/index.php?rid=3368482&amp;cid=c_1_34_f&amp;fid=36544&amp;url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-ClinicalTrials%2F%7E3%2F-8rCdQAIK8I%2Fviron-reports-positive-proof-concept-results-arthritis-vt-346-anti-tnf-therapeutic-9013.html</link>
            <description>LONDON, ON, March 16 /PRNewswire/ -- Viron Therapeutics Inc.
announced that VT-346, an anti-TNF protein therapeutic,
demonstrated positive results in a pivotal proof of concept study
in the gold standard transgenic mouse model for arthritis.... (Source: Drugs.com - Clinical Trials)</description>
            <author>Drugs.com - Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3368482</comments>
            <pubDate>Tue, 16 Mar 2010 12:40:30 +0100</pubDate>
            <guid isPermaLink="false">3368482</guid>        </item>
        <item>
            <title>Generic Drug For Type 2 Diabetes Passes Next Clinical Hurdle</title>
            <link>http://www.medworm.com/index.php?rid=3366773&amp;cid=c_1_26_f&amp;fid=23292&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2FUbfDDyyVNkU%2F3yWR</link>
            <description>Clinical studies of a generic drug called salsalate, widely prescribed for arthritis, now provide early promising results that it may be useful for the treatment of patients with type 2 diabetes as well. Salsalate is an atypical non-steroidal anti-inflammatory agent that is chemically similar to aspirin but a bit easier on the stomach. In a three-month trial of people with type 2 diabetes that was led by Joslin Diabetes Center researchers, those who took the drug showed significantly improved blood glucose levels... (Source: Health News from Medical News Today)</description>
            <author>Health News from Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3366773</comments>
            <pubDate>Tue, 16 Mar 2010 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">3366773</guid>        </item>
        <item>
            <title>Generic Drug For Type 2 Diabetes Passes Next Clinical Hurdle</title>
            <link>http://www.medworm.com/index.php?rid=3367550&amp;cid=c_1_15_f&amp;fid=33016&amp;url=http%3A%2F%2Fmnt.to%2Ff%2F3yWR</link>
            <description>Clinical studies of a generic drug called salsalate, widely prescribed for arthritis, now provide early promising results that it may be useful for the treatment of patients with type 2 diabetes as well. Salsalate is an atypical non-steroidal anti-inflammatory agent that is chemically similar to aspirin but a bit easier on the stomach... (Source: Diabetes News From Medical News Today)</description>
            <author>Diabetes News From Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3367550</comments>
            <pubDate>Tue, 16 Mar 2010 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">3367550</guid>        </item>
        <item>
            <title>NICE Draft Guidance Proposes Treatment Options For Psoriatic Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3366735&amp;cid=c_1_26_f&amp;fid=23292&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2FQMqzH6CByHw%2F3yWk</link>
            <description>The National Institute for Health and Clinical Excellence (NICE) has published draft guidance recommending etanercept (Enbrel, Wyeth Pharmaceuticals) and adalimumab (Humira, Abbott Laboratories) for the treatment of adults with active and progressive psoriatic arthritis when specific criteria are met. Infliximab (Remicade, Schering-Plough) is also recommended where neither etanercept nor adalimumab can be used... (Source: Health News from Medical News Today)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Health News from Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3366735</comments>
            <pubDate>Tue, 16 Mar 2010 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">3366735</guid>        </item>
        <item>
            <title>NICE Draft Guidance Proposes Treatment Options For Psoriatic Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3368886&amp;cid=c_1_41_f&amp;fid=29974&amp;url=http%3A%2F%2Fmnt.to%2Ff%2F3yWk</link>
            <description>The National Institute for Health and Clinical Excellence (NICE) has published draft guidance recommending etanercept (Enbrel, Wyeth Pharmaceuticals) and adalimumab (Humira, Abbott Laboratories) for the treatment of adults with active and progressive psoriatic arthritis when specific criteria are met... (Source: Arthritis News From Medical News Today)</description>
            <author>Arthritis News From Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3368886</comments>
            <pubDate>Tue, 16 Mar 2010 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">3368886</guid>        </item>
        <item>
            <title>Anti-thymocyte globulin plus etanercept as therapy for myelodysplastic syndromes (MDS): a phase II study</title>
            <link>http://www.medworm.com/index.php?rid=3367753&amp;cid=c_1_19_f&amp;fid=29464&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2141.2010.08145.x</link>
            <description>Immunosuppressive therapies have proven valuable in treating patients with myelodysplastic syndromes (MDS). We evaluated the combination of equine anti-thymocyte globulin (ATGAM®) and the soluble tumour necrosis factor receptor, etanercept (Enbrel®), in a phase II trial. Twenty-five patients with MDS [4-refractory anaemia (RA), 2-RA with ring sideroblasts, 15-refractory cytopenia with multilineage dysplasia (RCMD), 3-RCMD and ring sideroblasts, 1-RA with excess blasts type 1] in International Prognostic Staging System risk groups low (n = 11) or intermediate-1 (n = 14) were enrolled. All patients were platelet or red cell transfusion-dependent. Nineteen patients completed therapy with ATG at 40 mg/kg per day for four consecutive days, followed by etanercept, 25 mg subcutaneous twice a we...</description>
            <author>British Journal of Haematology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3367753</comments>
            <pubDate>Tue, 16 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3367753</guid>        </item>
        <item>
            <title>Cyclophilin&amp;#x2013;CD147 interactions: a new target for anti-inflammatory therapeutics</title>
            <link>http://www.medworm.com/index.php?rid=3371225&amp;cid=c_1_3_f&amp;fid=33580&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2249.2010.04115.x</link>
            <description>CD147 is a widely expressed plasma membrane protein that has been implicated in a variety of physiological and pathological activities. It is best known for its ability to function as extracellular matrix metalloproteinase inducer (hence the other name for this protein, EMMPRIN), but has also been shown to regulate lymphocyte responsiveness, monocarboxylate transporter expression and spermatogenesis. These functions reflect multiple interacting partners of CD147. Among these CD147-interacting proteins cyclophilins represent a particularly interesting class, both in terms of structural considerations and potential medical implications. CD147 has been shown to function as a signalling receptor for extracellular cyclophilins A and B and to mediate chemotactic activity of cyclophilins towards ...</description>
            <author>Clinical and Experimental Immunology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3371225</comments>
            <pubDate>Tue, 16 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3371225</guid>        </item>
        <item>
            <title>A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investigating mechanisms of pathogenesis</title>
            <link>http://www.medworm.com/index.php?rid=3371228&amp;cid=c_1_3_f&amp;fid=33580&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2249.2010.04110.x</link>
            <description>Human endogenous retroviruses (HERVs) are remnants of ancient retroviral infections within the human genome. These molecular fossils draw parallels with present-day exogenous retroviruses and have been linked previously with immunopathology within rheumatoid arthritis (RA). Mechanisms of pathogenesis for HERV-K in RA such as molecular mimicry were investigated. To clarify a role for HERVs in RA, potential autoantigens implicated in autoimmunity were scanned for sequence identity with retroviral epitopes. Short retroviral peptides modelling shared epitopes were synthesized, to survey anti-serum of RA patients and disease controls. A novel real-time polymerase chain reaction (PCR) assay was also developed to quantify accurately levels of HERV-K (HML-2) gag expression, relative to normalized ...</description>
            <author>Clinical and Experimental Immunology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3371228</comments>
            <pubDate>Tue, 16 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3371228</guid>        </item>
        <item>
            <title>Salsalate As a Type 2 Diabetes Treatment? It Looks Promising</title>
            <link>http://www.medworm.com/index.php?rid=3368212&amp;cid=c_1_26_f&amp;fid=39066&amp;url=http%3A%2F%2Fwww.usnews.com%2Farticles%2Fhealth%2Fmanaging-your-healthcare%2F2010%2F3%2F15%2Fsalsalate-as-a-type-2-diabetes-treatment-it-looks-promising.html%3Fs_cid%3Drss%3Asalsalate-as-a-type-2-diabetes-treatment-it-looks-promising</link>
            <description>A longtime arthritis medicine could one day be an affordable diabetes treatment. (Source: U.S. News - Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>U.S. News - Health</author>
            <type>consumer</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3368212</comments>
            <pubDate>Mon, 15 Mar 2010 21:05:00 +0100</pubDate>
            <guid isPermaLink="false">3368212</guid>        </item>
        <item>
            <title>Arthritis Drug May Fight Diabetes, Too</title>
            <link>http://www.medworm.com/index.php?rid=3367636&amp;cid=c_1_26_f&amp;fid=37163&amp;url=http%3A%2F%2Fwww.nlm.nih.gov%2Fenter%2Fmedlineplus%2Frss%3Ffeed%3DTodays%2520MedlinePlus%2520Health%2520News%26url%3Dhttp%253A%252F%252Fwww%252Enlm%252Enih%252Egov%252Fmedlineplus%252Fnews%252Ffullstory%255F96413%252Ehtml</link>
            <description>Study finds that salsalate helps control blood sugar levels

Source: HealthDay
Related MedlinePlus Pages: Arthritis, Diabetes, Medicines (Source: MedlinePlus Health News)</description>
            <author>MedlinePlus Health News</author>
            <type>consumer</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3367636</comments>
            <pubDate>Mon, 15 Mar 2010 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">3367636</guid>        </item>
        <item>
            <title>The Long-term Impact of Rituximab for Childhood Immune Thrombocytopenia</title>
            <link>http://www.medworm.com/index.php?rid=3372670&amp;cid=c_1_41_f&amp;fid=35949&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy36m3l6823604572%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Rituximab administered at standard doses induces universal B-cell depletion. It shows good efficacy in patients with a variety
 of autoimmune diseases and has been licensed for use in rheumatoid arthritis. Despite prolonged B-cell depletion, side effects
 appear to be minimal. The use of B-cell depletion in children in whom the immune system is more immature may have other unknown
 complications, although the literature remains sparse. This review summarizes the available studies of rituximab in children
 with immune thrombocytopenia and assesses some of the short-term and potential long-term consequences of B-cell depletion.
 Overall, rituximab appears well-tolerated in children. The incidence of serum sickness may be higher than it is in adults,
 but infections remain...</description>
            <author>Current Rheumatology Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3372670</comments>
            <pubDate>Mon, 15 Mar 2010 18:00:40 +0100</pubDate>
            <guid isPermaLink="false">3372670</guid>        </item>
        <item>
            <title>Hyperimmunoglobulin D Syndrome in Childhood</title>
            <link>http://www.medworm.com/index.php?rid=3372671&amp;cid=c_1_41_f&amp;fid=35949&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F785276x4x1136023%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hyperimmunoglobulinemia D and periodic fever syndrome, an autoinflammatory syndrome, is caused by mutations in the gene coding
 for mevalonate kinase. The disease is clinically characterized by recurrent attacks of fever accompanied by an array of inflammatory
 symptoms including lymphadenopathy, rash, arthritis, and gastrointestinal complaints. Most patients have their first attack
 in the first year of life, typically after a childhood vaccination. The frequency of attacks is highest during childhood,
 with a gradual decrease after adolescence. Frequent fever attacks impair quality of life and the achievement of educational
 milestones. Recent reports show promising results with anakinra and etanercept to treat the attacks.
 
 
	Content Type Journal ArticleDOI 10.1007...</description>
            <author>Current Rheumatology Reports</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3372671</comments>
            <pubDate>Mon, 15 Mar 2010 18:00:38 +0100</pubDate>
            <guid isPermaLink="false">3372671</guid>        </item>
        <item>
            <title>Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3369268&amp;cid=c_1_49_f&amp;fid=33862&amp;url=http%3A%2F%2Fjem.rupress.org%2Fcgi%2Fcontent%2Fshort%2F207%2F3%2F579%3Frss%3D1</link>
            <description>DNAX adaptor protein 12 (DAP12) is a trans-membrane adaptor molecule that transduces activating signals in NK and myeloid cells. Absence of functional Dap12 results in osteoclast defects and bone abnormalities. Because DAP12 has no extracelluar binding domains, it must pair with cell surface receptors for signal transduction. There are at least 15 known DAP12-associating cell surface receptors with distinct temporal and cell type&amp;ndash;specific expression patterns. Our aim was to determine which receptors may be important in DAP12-associated bone pathologies. Here, we identify myeloid DAP12-associating lectin (MDL)-1 receptor (also known as CLEC5A) as a key regulator of synovial injury and bone erosion during autoimmune joint inflammation. Activation of MDL-1 leads to enhanced recruitment ...</description>
            <author>The Journal of Experimental Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3369268</comments>
            <pubDate>Mon, 15 Mar 2010 17:12:57 +0100</pubDate>
            <guid isPermaLink="false">3369268</guid>        </item>
        <item>
            <title>NICE publishes new arthritis advice</title>
            <link>http://www.medworm.com/index.php?rid=3364735&amp;cid=c_1_27_f&amp;fid=36851&amp;url=http%3A%2F%2Fwww.nursinginpractice.com%2Fdefault.asp%3Ftitle%3DNICEpublishesnewarthritisadvice%26page%3Darticle.display%26article.id%3D20744</link>
            <description>NICE has updated its draft guidance on the use of etanercept and adalimumab for adults with active and progressive psoriatic arthritis (Source: Nursing in Practice)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Nursing in Practice</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3364735</comments>
            <pubDate>Mon, 15 Mar 2010 15:02:10 +0100</pubDate>
            <guid isPermaLink="false">3364735</guid>        </item>
        <item>
            <title>Pediatric Lyme Arthritis Twice as Common as Septic Arthritis in Endemic Areas of Lyme Disease</title>
            <link>http://www.medworm.com/index.php?rid=3366077&amp;cid=c_1_26_f&amp;fid=36062&amp;url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F718480%3Fsrc%3Drss</link>
            <description>Pediatric joint effusions are more likely to be due to Lyme arthritis than septic arthritis in the Northeastern United States and other areas where Lyme disease is more prevalent.  Medscape Medical News (Source: Medscape Today Headlines)</description>
            <author>Medscape Today Headlines</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3366077</comments>
            <pubDate>Mon, 15 Mar 2010 14:48:05 +0100</pubDate>
            <guid isPermaLink="false">3366077</guid>        </item>
        <item>
            <title>Do quick workouts beat long ones?</title>
            <link>http://www.medworm.com/index.php?rid=3368169&amp;cid=c_1_26_f&amp;fid=23300&amp;url=http%3A%2F%2Fwww.nhs.uk%2Fnews%2F2010%2F03March%2FPages%2Fshort-workouts-better-than-long-claim.aspx</link>
            <description>Conclusion
This small observational study has demonstrated an improvement in muscle health following low-volume, high-intensity training in seven healthy men. There are a number of points to keep in mind when considering the results of this research, including:

  The small sample size. The study included only seven men with an average age of 21. The researchers report that they were healthy and “recreationally active two or three times a week”, but that “none were engaged in a structured exercise training programme”. The results of the study cannot therefore be taken to represent the wider population, particularly older people. 
  This study lacked a comparator group. While newspapers have reported that short bursts of high-intensity exercise are as effective as longer-term traini...</description>
            <author>NHS News Feed</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3368169</comments>
            <pubDate>Mon, 15 Mar 2010 14:42:00 +0100</pubDate>
            <guid isPermaLink="false">3368169</guid>        </item>
        <item>
            <title>The PTPN22 R620W polymorphism is not associated with systemic rheumatic diseases in South Africans</title>
            <link>http://www.medworm.com/index.php?rid=3365306&amp;cid=c_1_41_f&amp;fid=29969&amp;url=http%3A%2F%2Frheumatology.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F49%2F4%2F820%3Frss%3D1</link>
            <description>(Source: Rheumatology)</description>
            <author>Rheumatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365306</comments>
            <pubDate>Mon, 15 Mar 2010 13:35:47 +0100</pubDate>
            <guid isPermaLink="false">3365306</guid>        </item>
        <item>
            <title>Cost-effectiveness modelling of biological treatment sequences in moderate to severe rheumatoid arthritis in France</title>
            <link>http://www.medworm.com/index.php?rid=3365295&amp;cid=c_1_41_f&amp;fid=29969&amp;url=http%3A%2F%2Frheumatology.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F49%2F4%2F733%3Frss%3D1</link>
            <description>Conclusion. Advanced simulation models based on clinical evidence and medical practice appear to be a promising approach for comparing cost-effectiveness of biologic strategies in RA. (Source: Rheumatology)</description>
            <author>Rheumatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365295</comments>
            <pubDate>Mon, 15 Mar 2010 13:35:46 +0100</pubDate>
            <guid isPermaLink="false">3365295</guid>        </item>
        <item>
            <title>How to improve DAS28 use in daily clinical practice?--a pilot study of a nurse-led intervention</title>
            <link>http://www.medworm.com/index.php?rid=3365296&amp;cid=c_1_41_f&amp;fid=29969&amp;url=http%3A%2F%2Frheumatology.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F49%2F4%2F741%3Frss%3D1</link>
            <description>Conclusions. DAS28 measurement by a nurse was as effective as usual care; however, this intervention without protocolized treatment adjustments is not sufficient to lead to a considerable reduction in disease activity compared with trials with protocolized treatment adjustments. (Source: Rheumatology)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Rheumatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365296</comments>
            <pubDate>Mon, 15 Mar 2010 13:35:46 +0100</pubDate>
            <guid isPermaLink="false">3365296</guid>        </item>
        <item>
            <title>Cost-utility of different treatment strategies after the failure of tumour necrosis factor inhibitor in rheumatoid arthritis in the Finnish setting</title>
            <link>http://www.medworm.com/index.php?rid=3365300&amp;cid=c_1_41_f&amp;fid=29969&amp;url=http%3A%2F%2Frheumatology.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F49%2F4%2F767%3Frss%3D1</link>
            <description>Conclusions. Treatment with RTX is a cost-effective treatment strategy in RA patients in Finland. (Source: Rheumatology)</description>
            <author>Rheumatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365300</comments>
            <pubDate>Mon, 15 Mar 2010 13:35:46 +0100</pubDate>
            <guid isPermaLink="false">3365300</guid>        </item>
        <item>
            <title>Activated fibrocytes: Circulating cells that populate the arthritic synovium?</title>
            <link>http://www.medworm.com/index.php?rid=3365280&amp;cid=c_1_41_f&amp;fid=29969&amp;url=http%3A%2F%2Frheumatology.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F49%2F4%2F617%3Frss%3D1</link>
            <description>(Source: Rheumatology)</description>
            <author>Rheumatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365280</comments>
            <pubDate>Mon, 15 Mar 2010 13:35:45 +0100</pubDate>
            <guid isPermaLink="false">3365280</guid>        </item>
        <item>
            <title>NICE guidance on rheumatoid arthritis: Implications and challenges for rheumatologists</title>
            <link>http://www.medworm.com/index.php?rid=3365281&amp;cid=c_1_41_f&amp;fid=29969&amp;url=http%3A%2F%2Frheumatology.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F49%2F4%2F619%3Frss%3D1</link>
            <description>(Source: Rheumatology)</description>
            <author>Rheumatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365281</comments>
            <pubDate>Mon, 15 Mar 2010 13:35:45 +0100</pubDate>
            <guid isPermaLink="false">3365281</guid>        </item>
        <item>
            <title>Fibrocyte activation in rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3365284&amp;cid=c_1_41_f&amp;fid=29969&amp;url=http%3A%2F%2Frheumatology.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F49%2F4%2F640%3Frss%3D1</link>
            <description>Conclusions. These data suggest that activated fibrocytes may influence the disease process in RA and may serve as surrogate markers for disease in the PB of affected patients. (Source: Rheumatology)</description>
            <author>Rheumatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365284</comments>
            <pubDate>Mon, 15 Mar 2010 13:35:45 +0100</pubDate>
            <guid isPermaLink="false">3365284</guid>        </item>
        <item>
            <title>Association between transforming growth factor-{beta}1 T869C polymorphism and rheumatoid arthritis: a meta-analysis</title>
            <link>http://www.medworm.com/index.php?rid=3365285&amp;cid=c_1_41_f&amp;fid=29969&amp;url=http%3A%2F%2Frheumatology.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F49%2F4%2F652%3Frss%3D1</link>
            <description>Conclusions. There was heterogeneity between studies, and no clear evidence of an association on a worldwide population was observed. Subgroup analysis results suggest that TGF-&amp;beta;1 T869C might play a role in RA susceptibility for Asians but not for non-Asians. Further studies are required for definite conclusions. (Source: Rheumatology)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Rheumatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365285</comments>
            <pubDate>Mon, 15 Mar 2010 13:35:45 +0100</pubDate>
            <guid isPermaLink="false">3365285</guid>        </item>
        <item>
            <title>Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases</title>
            <link>http://www.medworm.com/index.php?rid=3365288&amp;cid=c_1_41_f&amp;fid=29969&amp;url=http%3A%2F%2Frheumatology.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F49%2F4%2F671%3Frss%3D1</link>
            <description>Conclusion. The most enhanced proteins in RA SF, the S100A8, S100A9 and S00A12 proteins, distinguished RA from MIA with high accuracy. Possible implication of resident cells in this increase may play a role in RA physiopathology. (Source: Rheumatology)</description>
            <author>Rheumatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365288</comments>
            <pubDate>Mon, 15 Mar 2010 13:35:45 +0100</pubDate>
            <guid isPermaLink="false">3365288</guid>        </item>
        <item>
            <title>Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard</title>
            <link>http://www.medworm.com/index.php?rid=3365289&amp;cid=c_1_41_f&amp;fid=29969&amp;url=http%3A%2F%2Frheumatology.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F49%2F4%2F683%3Frss%3D1</link>
            <description>Conclusions. Our results suggest that the SDAI classification of remission is closer to the concept of an absence of inflammatory activity, as defined by the absence of positive PD signal by US. (Source: Rheumatology)</description>
            <author>Rheumatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365289</comments>
            <pubDate>Mon, 15 Mar 2010 13:35:45 +0100</pubDate>
            <guid isPermaLink="false">3365289</guid>        </item>
        <item>
            <title>Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register</title>
            <link>http://www.medworm.com/index.php?rid=3365291&amp;cid=c_1_41_f&amp;fid=29969&amp;url=http%3A%2F%2Frheumatology.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F49%2F4%2F697%3Frss%3D1</link>
            <description>Conclusions. Anti-TNF therapies have a good response rate in PsA, and have an adverse event profile similar to that seen in a control cohort of patients with seronegative arthritis receiving DMARD therapy. (Source: Rheumatology)</description>
            <author>Rheumatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365291</comments>
            <pubDate>Mon, 15 Mar 2010 13:35:45 +0100</pubDate>
            <guid isPermaLink="false">3365291</guid>        </item>
        <item>
            <title>NICE recommends three new arthritis therapies</title>
            <link>http://www.medworm.com/index.php?rid=3364741&amp;cid=c_1_27_f&amp;fid=38049&amp;url=http%3A%2F%2Fwww.nursingtimes.net%2Fnursing-practice-clinical-research%2Fnurse-prescribing%2Fnice-recommends-three-new-arthritis-therapies%2F5012593.article%3Freferrer%3DRSS</link>
            <description>Three new treatments for psoriatic arthritis have been recommended for use by the National Institute for Health and Clinical Excellence (NICE). (Source: Nursing Times Breaking News)</description>
            <author>Nursing Times Breaking News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3364741</comments>
            <pubDate>Mon, 15 Mar 2010 11:38:00 +0100</pubDate>
            <guid isPermaLink="false">3364741</guid>        </item>
        <item>
            <title>Developments in the Clinical Understanding of Lupus</title>
            <link>http://www.medworm.com/index.php?rid=3364183&amp;cid=c_1_26_f&amp;fid=36062&amp;url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F717474%3Fsrc%3Drss</link>
            <description>Progress in understanding the pathogenic underpinnings of SLE bodes well for the development of new therapeutic agents.  Arthritis Research &amp; Therapy (Source: Medscape Today Headlines)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Medscape Today Headlines</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3364183</comments>
            <pubDate>Mon, 15 Mar 2010 11:04:35 +0100</pubDate>
            <guid isPermaLink="false">3364183</guid>        </item>
        <item>
            <title>High-Impact Sports Might Not Harm Knee Replacements</title>
            <link>http://www.medworm.com/index.php?rid=3368887&amp;cid=c_1_41_f&amp;fid=29977&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D114367%26k%3DArthritis_General</link>
            <description>Title: High-Impact Sports Might Not Harm Knee ReplacementsCategory: Health NewsCreated: 3/12/2010 10:10:00 AMLast Editorial Review: 3/15/2010 (Source: MedicineNet Arthritis General)</description>
            <author>MedicineNet Arthritis General</author>
            <type>consumer</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3368887</comments>
            <pubDate>Mon, 15 Mar 2010 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">3368887</guid>        </item>
        <item>
            <title>Study: Total Knee Replacement Improves Balance, Relieves Pain</title>
            <link>http://www.medworm.com/index.php?rid=3364593&amp;cid=c_1_26_f&amp;fid=23290&amp;url=http%3A%2F%2Fwww.ivanhoe.com%2Fchannels%2Fp_channelstory.cfm%3Fstoryid%3D23761</link>
            <description>(Ivanhoe Newswire) -- Total knee replacement (TKR) successfully relieves pain and improves function in patients with advanced knee arthritis, according to a new study. Researchers found the surgery also improves balance among elderly patients. (Source: Medical Headlines From Ivanhoe.com)</description>
            <author>Medical Headlines From Ivanhoe.com</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3364593</comments>
            <pubDate>Mon, 15 Mar 2010 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">3364593</guid>        </item>
        <item>
            <title>Golimumab: a guide to its use in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis</title>
            <link>http://www.medworm.com/index.php?rid=3364603&amp;cid=c_1_13_f&amp;fid=33931&amp;url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fdtp%2F2010%2F00000026%2F00000004%2Fart00001</link>
            <description>(Source: Drugs)</description>
            <author>Drugs</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3364603</comments>
            <pubDate>Mon, 15 Mar 2010 02:05:42 +0100</pubDate>
            <guid isPermaLink="false">3364603</guid>        </item>
        <item>
            <title>Scientists identify genes for codeine and morphine</title>
            <link>http://www.medworm.com/index.php?rid=3365629&amp;cid=c_1_58_f&amp;fid=36473&amp;url=http%3A%2F%2Fwww.guardian.co.uk%2Fscience%2F2010%2Fmar%2F15%2Fopium-poppy-codeine-morphine-genes</link>
            <description>Discovery raises possibility of manufacturing painkillers more cheaply using vats of microbes rather than fields of flowersScientists have identified the two genes in opium poppies which are used to make codeine and morphine, two of the most important painkillers in a doctor's armoury.The discovery opens the door to alternative ways of making the drugs which do not involve giving over vast areas of farmland to growing the flowers. One hope is to transfer the genes into microbes, which could be grown in vats and provide huge quantities of the drugs at a fraction of the cost of farming and processing the plants.Researchers said the findings could lead to the creation of strains of opium poppies that cannot make morphine, the opiate chemical turned into heroin and exported from Afghanistan an...</description>
            <author>Guardian Unlimited Science</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365629</comments>
            <pubDate>Mon, 15 Mar 2010 00:02:06 +0100</pubDate>
            <guid isPermaLink="false">3365629</guid>        </item>
        <item>
            <title>Genes for codeine and morphine identified</title>
            <link>http://www.medworm.com/index.php?rid=3369447&amp;cid=c_1_58_f&amp;fid=36473&amp;url=http%3A%2F%2Fwww.guardian.co.uk%2Fscience%2F2010%2Fmar%2F15%2Fopium-poppy-codeine-morphine-genes</link>
            <description>Discovery raises possibility of manufacturing painkillers more cheaply using vats of microbes rather than fields of flowersScientists have identified the two genes in opium poppies which are used to make codeine and morphine, two of the most important painkillers in a doctor's armoury.The discovery opens the door to alternative ways of making the drugs which do not involve giving over vast areas of farmland to growing the flowers. One hope is to transfer the genes into microbes, which could be grown in vats and provide huge quantities of the drugs at a fraction of the cost of farming and processing the plants.Researchers said the findings could lead to the creation of strains of opium poppies that cannot make morphine, the opiate chemical turned into heroin and exported from Afghanistan an...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Guardian Unlimited Science</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3369447</comments>
            <pubDate>Mon, 15 Mar 2010 00:02:06 +0100</pubDate>
            <guid isPermaLink="false">3369447</guid>        </item>
        <item>
            <title>Effectiveness of adalimumab in treating patients with ankylosing spondylitis associated with enthesitis and peripheral arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3364697&amp;cid=c_1_22_f&amp;fid=30439&amp;url=http%3A%2F%2Farthritis-research.com%2Fcontent%2F12%2F2%2FR43</link>
            <description>Conclusions:
Treatment with adalimumab improved enthesitis and peripheral arthritis in patients with active AS.Trial registration: ClinicalTrials.gov NCT00478660. (Source: BioMed Central)</description>
            <author>BioMed Central</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3364697</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3364697</guid>        </item>
        <item>
            <title>Live polio vaccine exposure while receiving anti-TNF therapy for reactive arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3365313&amp;cid=c_1_41_f&amp;fid=29971&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1756-185X.2010.01466.x</link>
            <description>International guidelines state that live vaccines are contraindicated in patients on anti-TNF therapy. However, we report the experience of a patient who inadvertently received live polio vaccine whilst receiving anti-TNF therapy. Patient did not suffer from any infectious sequel as a result. No clear guidelines are available for all vaccines in patients with specific rheumatic diseases. However, if we consider adult patients with rheumatic diseases to have altered immunocompetence, it is recommended that they receive the usual inactivated vaccines according to standard schedules, and live vaccines should be avoided in those who are treated with more potent forms of immune suppression. Patients should be counseled regarding the risks of live vaccines prior to treatment with anti-TNF therap...</description>
            <author>APLAR Journal of Rheumatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365313</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3365313</guid>        </item>
        <item>
            <title>Foot deformities in patients with rheumatoid arthritis: the relationship with foot functions</title>
            <link>http://www.medworm.com/index.php?rid=3365314&amp;cid=c_1_41_f&amp;fid=29971&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1756-185X.2010.01465.x</link>
            <description>Conclusions: In this study, it has been shown that foot deformities are frequent in patients with RA and that there is slight deterioration in foot functions related to RA. Our results indicated that foot deformities have small, but clinically important changes on foot functions. There is a need for more studies, which evaluates the foot deformities, to further explore the relationship between the foot deformities and foot function in patients with RA. (Source: APLAR Journal of Rheumatology)</description>
            <author>APLAR Journal of Rheumatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365314</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3365314</guid>        </item>
        <item>
            <title>Incidence of gastroduodenal ulcers during treatment with celecoxib or diclofenac: pooled results from three 12-week trials in Chinese patients with osteoarthritis or rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3365316&amp;cid=c_1_41_f&amp;fid=29971&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1756-185X.2010.01463.x</link>
            <description>Conclusions: In Asian patients with minimal significant risk factors, treatment with celecoxib was associated with a modest but significantly reduced incidence of gastric ulcers at the end of 12 weeks. (Source: APLAR Journal of Rheumatology)</description>
            <author>APLAR Journal of Rheumatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365316</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3365316</guid>        </item>
        <item>
            <title>Daytime patterning of fatigue and its associations with the previous night's discomfort and poor sleep among women with primary Sjögren's syndrome or rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3365732&amp;cid=c_1_66_f&amp;fid=33607&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fmsc.174</link>
            <description>Conclusions: Fatigue management for people with rheumatic disease could include strategies for coping with discomfort at night and difficulties in sleeping. Further research into ameliorating fatigue should include assessments of persistent discomfort or periods of insomnia and identify disease-specific needs that require targeted intervention. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: Musculoskeletal Care)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Musculoskeletal Care</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365732</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3365732</guid>        </item>
        <item>
            <title>Self-efficacy in rheumatoid arthritis: translation and test of validity, reliability and sensitivity of the Danish version of the Rheumatoid Arthritis Self-Efficacy Questionnaire (RASE)</title>
            <link>http://www.medworm.com/index.php?rid=3365733&amp;cid=c_1_66_f&amp;fid=33607&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fmsc.172</link>
            <description>Conclusion: RASE-DK met the appropriate standards for validity, reliability and sensitivity, and is appropriate for use in Denmark. However, the concept of self-efficacy may be too abstract for a few individuals, and relaxation is interpreted in various ways by the Danish patients. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: Musculoskeletal Care)</description>
            <author>Musculoskeletal Care</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365733</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3365733</guid>        </item>
        <item>
            <title>Two additive mechanisms impair the differentiation of
'substrate-selective' p38 inhibitors from classical p38 inhibitors in vitro</title>
            <link>http://www.medworm.com/index.php?rid=3365738&amp;cid=c_1_67_f&amp;fid=34051&amp;url=http%3A%2F%2Fwww.biomedcentral.com%2F1752-0509%2F4%2F23</link>
            <description>Conclusions:
Our integrated mechanistic modeling and experimental validation provides an example of how systems biology approaches can be applied to drug discovery and provide a basis for decision-making with limited chemical matter. We find that, given our current understanding, it is unlikely that 'substrate-selective' inhibitors of p38 will work as originally intended when placed in the context of more complex cellular environments, largely due to a stoichiometric excess of MK2 relative to p38. (Source: BMC Systems Biology - Latest articles)</description>
            <author>BMC Systems Biology  - Latest articles</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365738</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3365738</guid>        </item>
        <item>
            <title>NICE issues preliminary recommendations (ACD) for etanercept, infliximab, &amp; adalimumab for psoriatic arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3367512&amp;cid=c_1_13_f&amp;fid=38936&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FNews%2F2010---March%2F15%2FNICE-issues-preliminary-recommendations-ACD-for-etanercept-infliximab--adalimumab-for-psoriatic-arthritis%2F</link>
            <description>Source: NICE
Area: News
 The National Institute for Health and Clinical Excellence (NICE) has published an &quot;appraisal consultation document&quot; on the use of etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis. The appraisal Committee's preliminary recommendations are (taken directly from source): 
 &amp;nbsp; 
 1. Etanercept and adalimumab are recommended for the treatment of adults with active and progressive psoriatic arthritis when the following criteria are met. .&amp;nbsp;The person has peripheral arthritis with three or more tender joints and three or more swollen joints. .&amp;nbsp;The psoriatic arthritis has not responded to adequate trials of at least two standard disease-modifying antirheumatic drugs (DMARDs), administered either individually or in combination. 
 &amp;nb...</description>
            <author>NeLM - News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3367512</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3367512</guid>        </item>
        <item>
            <title>Psychological well-being in rheumatoid arthritis: a review of the literature</title>
            <link>http://www.medworm.com/index.php?rid=3369722&amp;cid=c_1_66_f&amp;fid=33607&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fmsc.171</link>
            <description>The psychological well-being of patients with rheumatoid arthritis (RA) is an important issue, and the advent of measurement tools has led to a better understanding of the mental aspects associated with this chronic illness. Patients with RA are more likely to suffer from anxiety, depression and low self-esteem, with high levels of associated mortality and suicide. The loss of the ability to carry out daily functions owing to RA is also associated with the onset of depressive symptoms. Furthermore, the psychological effects of RA can extend to the partners, families and carers of sufferers. Conventional treatment has focused on treating the symptoms of RA and containment of disease progression, but may not necessarily address the psychological issues associated with the condition. Furtherm...</description>
            <author>Musculoskeletal Care</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3369722</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3369722</guid>        </item>
        <item>
            <title>Evaluation of the Personal Impact Health Assessment Questionnaire (PI HAQ) to capture the impact of disability in osteoarthritis</title>
            <link>http://www.medworm.com/index.php?rid=3369723&amp;cid=c_1_66_f&amp;fid=33607&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fmsc.170</link>
            <description>Conclusions: These studies provide an initial evaluation of an instrument to measure the personal impact of disability in people with OA, setting disability within a personal context. Further studies, including sensitivity to change, are required. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: Musculoskeletal Care)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Musculoskeletal Care</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3369723</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3369723</guid>        </item>
        <item>
            <title>Relative Over-Reactivity of Human versus Chimpanzee Lymphocytes: Implications for the Human Diseases Associated with Immune Activation.</title>
            <link>http://www.medworm.com/index.php?rid=3374722&amp;cid=c_1_3_f&amp;fid=33860&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20231688%26dopt%3DAbstract</link>
            <description>In this study, we show that human T cells are more reactive than chimpanzee T cells to a wide variety of stimuli, including anti-TCR Abs of multiple isotypes, l-phytohemagglutin, Staphylococcus aureus superantigen, a superagonist anti-CD28 Ab, and in MLRs. We also extend this observation to B cells, again showing a human propensity to react more strongly to stimuli. Finally, we show a relative increase in activation markers and cytokine production in human lymphocytes in response to uridine-rich (viral-like) ssRNA. Thus, humans manifest a generalized lymphocyte over-reactivity relative to chimpanzees, a finding that is correlated with decreased levels of inhibitory sialic acid-recognizing Ig-superfamily lectins (Siglecs; particularly Siglec-5) on human T and B cells. Furthermore, Siglec-5 ...</description>
            <author>Journal of Immunology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3374722</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3374722</guid>        </item>
        <item>
            <title>Immunodominant T cell epitopes of hnRNP-A2 associated with disease activity in patients with rheumatoid arthritis.</title>
            <link>http://www.medworm.com/index.php?rid=3374734&amp;cid=c_1_3_f&amp;fid=33855&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20232340%26dopt%3DAbstract</link>
            <description>Authors: Trembleau S, Hoffmann M, Meyer B, Nell V, Radner H, Zauner W, Hammer J, Aichinger G, Fischer G, Smolen J, Steiner G
    The heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) has been described as important autoantigen in rheumatoid arthritis (RA) since it is targeted by autoantibodies, autoreactive T cells, and is aberrantly expressed in synovial cells in patients. To identify hnRNP-A2-specific T cell epitopes possibly associated with pathogenicity, we used an innovative approach. We first scanned 280 overlapping hnRNP-A2 peptides for binding to the RA-associated class II molecules HLA-DR4 and HLA-DR1, leading to a comprehensive selection of binders. The finally selected peptides were tested in IFN-gamma-specific ELISPOT assay: PBMC from 18% of RA patients showed a significant...</description>
            <author>European Journal of Immunology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3374734</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3374734</guid>        </item>
        <item>
            <title>Health Literacy Predicts the Discrepancy Between Patient and Provider Global Assessments of Rheumatoid Arthritis Activity at a Public Urban Rheumatology Clinic.</title>
            <link>http://www.medworm.com/index.php?rid=3378954&amp;cid=c_1_41_f&amp;fid=29982&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20231210%26dopt%3DAbstract</link>
            <description>CONCLUSION: Health literacy was independently associated with the extent of discrepancy between PTGA and MDGA in English-speaking patients with RA at an urban clinic. This finding should influence our interpretation of disease measures.
    PMID: 20231210 [PubMed - as supplied by publisher] (Source: J Rheumatol)</description>
            <author>J Rheumatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3378954</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3378954</guid>        </item>
        <item>
            <title>Risk Factors for Axial Inflammatory Arthritis in Patients with Psoriatic Arthritis.</title>
            <link>http://www.medworm.com/index.php?rid=3378955&amp;cid=c_1_41_f&amp;fid=29982&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20231209%26dopt%3DAbstract</link>
            <description>CONCLUSION: These results suggest that severe peripheral arthritis and HLA-B*27 are risk factors for AxPsA.
    PMID: 20231209 [PubMed - as supplied by publisher] (Source: J Rheumatol)</description>
            <author>J Rheumatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3378955</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3378955</guid>        </item>
        <item>
            <title>Interstitial Lung Disease Associated with Anti-PM/Scl or Anti-Aminoacyl-tRNA Synthetase Autoantibodies: A Similar Condition?</title>
            <link>http://www.medworm.com/index.php?rid=3378956&amp;cid=c_1_41_f&amp;fid=29982&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20231208%26dopt%3DAbstract</link>
            <description>CONCLUSION: Anti-PM/Scl and anti-ARS antibodies are associated with similar clinical manifestations, with the exception only of more overt myositis in the latter, therefore challenging the clinical specificity of the antisynthetase syndrome.
    PMID: 20231208 [PubMed - as supplied by publisher] (Source: J Rheumatol)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>J Rheumatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3378956</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3378956</guid>        </item>
        <item>
            <title>Cytokine Profiles of Macrophage Activation Syndrome Associated with Rheumatic Diseases.</title>
            <link>http://www.medworm.com/index.php?rid=3378957&amp;cid=c_1_41_f&amp;fid=29982&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20231207%26dopt%3DAbstract</link>
            <description>CONCLUSION: The cytokine profiles associated with MAS differed between patients with SLE and patients with AOSD. The patients with SLE showed a prominent increase in serum M-CSF levels, as did the patients with AOSD in serum IL-18 level. Patients who died had higher serum M-CSF and ss2m levels, and this suggests that aggressive treatment for patients with MAS and these profiles should be promptly started.
    PMID: 20231207 [PubMed - as supplied by publisher] (Source: J Rheumatol)</description>
            <author>J Rheumatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3378957</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3378957</guid>        </item>
        <item>
            <title>Genetic Variations in Genes Encoding RANK, RANKL, and OPG in Rheumatoid Arthritis: A Case-Control Study.</title>
            <link>http://www.medworm.com/index.php?rid=3378959&amp;cid=c_1_41_f&amp;fid=29982&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20231205%26dopt%3DAbstract</link>
            <description>CONCLUSION: The minor allele of the RANK SNP rs35211496 may be protective against RA, while the minor alleles of the RANKL SNP rs2277438 may increase susceptibility to RA.
    PMID: 20231205 [PubMed - as supplied by publisher] (Source: J Rheumatol)</description>
            <author>J Rheumatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3378959</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3378959</guid>        </item>
        <item>
            <title>Relationship Between Arterial Stiffness and Stanford Health Assessment Questionnaire Disability in Rheumatoid Arthritis Patients without Overt Arterial Disease.</title>
            <link>http://www.medworm.com/index.php?rid=3378961&amp;cid=c_1_41_f&amp;fid=29982&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20231203%26dopt%3DAbstract</link>
            <description>CONCLUSION: In patients with RA who are free of overt arterial disease, higher RA disability is associated with increased arterial stiffness independently of traditional cardiovascular risk factors and RA characteristics.
    PMID: 20231203 [PubMed - as supplied by publisher] (Source: J Rheumatol)</description>
            <author>J Rheumatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3378961</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3378961</guid>        </item>
        <item>
            <title>Single-joint Outcome Measures: Preliminary Validation of Patient-reported Outcomes and Physical Examination.</title>
            <link>http://www.medworm.com/index.php?rid=3378962&amp;cid=c_1_41_f&amp;fid=29982&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20231202%26dopt%3DAbstract</link>
            <description>CONCLUSION: Single-joint PRO, particularly the TJ global score, are simple to administer and demonstrate construct validity and responsiveness in patients with inflammatory arthritis. (ClinicalTrials.gov identifier NCT00126724).
    PMID: 20231202 [PubMed - as supplied by publisher] (Source: J Rheumatol)</description>
            <author>J Rheumatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3378962</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3378962</guid>        </item>
        <item>
            <title>Risk Factor Profiles for Atherosclerotic Cardiovascular Disease in Black and Other Africans with Established Rheumatoid Arthritis.</title>
            <link>http://www.medworm.com/index.php?rid=3378963&amp;cid=c_1_41_f&amp;fid=29982&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20231201%26dopt%3DAbstract</link>
            <description>CONCLUSION: The overall conventional and nonconventional atherosclerotic CVD risk burdens and arterial stiffness were not reduced in black patients with RA. CVD risk should be assessed and managed independent of ethnic origin and epidemiological transition stage in RA.
    PMID: 20231201 [PubMed - as supplied by publisher] (Source: J Rheumatol)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>J Rheumatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3378963</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3378963</guid>        </item>
        <item>
            <title>Decreased Circulating CD28-negative T Cells in Patients with Rheumatoid Arthritis Treated with Abatacept Are Correlated with Clinical Response.</title>
            <link>http://www.medworm.com/index.php?rid=3378964&amp;cid=c_1_41_f&amp;fid=29982&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20231200%26dopt%3DAbstract</link>
            <description>CONCLUSION: After therapy with abatacept, circulating CD28- T cells and other effector populations decrease in patients with RA. This decrease is correlated with clinical response.
    PMID: 20231200 [PubMed - as supplied by publisher] (Source: J Rheumatol)</description>
            <author>J Rheumatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3378964</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3378964</guid>        </item>
        <item>
            <title>Reproducibility of Joint Swelling Assessment by Sonography in Patients with Long-lasting Rheumatoid Arthritis (SEA-Repro Study Part II).</title>
            <link>http://www.medworm.com/index.php?rid=3378967&amp;cid=c_1_41_f&amp;fid=29982&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20231197%26dopt%3DAbstract</link>
            <description>CONCLUSION: PD findings explain most of the difference between clinical and sonographic joint assessments for synovitis in patients with long-standing RA.
    PMID: 20231197 [PubMed - as supplied by publisher] (Source: J Rheumatol)</description>
            <author>J Rheumatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3378967</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3378967</guid>        </item>
        <item>
            <title>Lack of Association Between the rs6920220 (G/A) Polymorphism of the 6q23 Region and Biopsy-proven Giant Cell Arteritis.</title>
            <link>http://www.medworm.com/index.php?rid=3378969&amp;cid=c_1_41_f&amp;fid=29982&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20231195%26dopt%3DAbstract</link>
            <description>CONCLUSION: Our results show no involvement of this 6q23/TNFAIP3 gene region SNP in the susceptibility to or clinical expression of GCA.
    PMID: 20231195 [PubMed - as supplied by publisher] (Source: J Rheumatol)</description>
            <author>J Rheumatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3378969</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3378969</guid>        </item>
        <item>
            <title>Minimally Important Difference for Patient-reported Outcomes in Psoriatic Arthritis: Health Assessment Questionnaire and Pain, Fatigue, and Global Visual Analog Scales.</title>
            <link>http://www.medworm.com/index.php?rid=3378971&amp;cid=c_1_41_f&amp;fid=29982&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20231193%26dopt%3DAbstract</link>
            <description>CONCLUSION: This is the first study investigating MID of patient-reported outcomes in PsA. MID for HAQ-DI, pain, and global VAS were shown to be the best predictors for a patient's perception of overall changes in disease status.
    PMID: 20231193 [PubMed - as supplied by publisher] (Source: J Rheumatol)</description>
            <author>J Rheumatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3378971</comments>
            <pubDate>Mon, 15 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3378971</guid>        </item>
        <item>
            <title>Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3368891&amp;cid=c_1_41_f&amp;fid=33456&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fyk3r82h6j61203q6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A 64-year-old woman suffering from progressive amyloid A (AA) amyloidosis of the gastrointestinal (GI) tract, associated with
 active rheumatoid arthritis, was transferred to our hospital due to hypovolemic shock. Although intensive care, including
 treatment with prednisolone and methotrexate, improved the hypovolemic shock, paralytic ileus became dominant instead of the
 marked diarrhea, suggesting the terminal stage of AA amyloidosis of the GI tract. Thus, we administered tocilizumab, a humanized
 anti-interleukin 6 receptor antibody (8&amp;nbsp;mg/kg, repeated every 4&amp;nbsp;weeks). Two weeks after the first injection of tocilizumab,
 serum AA rapidly returned to their normal ranges in accordance with the amelioration of paralytic ileus and systemic joint
 pain. Surprisin...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Clinical Rheumatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3368891</comments>
            <pubDate>Sun, 14 Mar 2010 12:25:46 +0100</pubDate>
            <guid isPermaLink="false">3368891</guid>        </item>
        <item>
            <title>Anti-agalactosyl IgG antibody in ankylosing spondylitis and psoriatic arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3368893&amp;cid=c_1_41_f&amp;fid=33456&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx62617622p073225%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Anti-agalactosyl IgG antibody (anti-Gal(0) IgG) has been regarded as a useful serological marker for rheumatoid arthritis
 (RA). It is unknown whether it is also elevated in serum and implicated in the pathogenesis of joint inflammation in seronegative
 spondyloarthropathy (SpA) such as ankylosing spondylitis (AS) and psoriatic arthritis (PsA). Sera were collected from 43 patients
 with AS or PsA with axial joint involvement, 22 patients with RA, and 25 healthy normal individuals for the detection of anti-Gal(0)
 IgG with a cup-type lectin enzyme immunoassay (Eitest CA.RF). The disease activity of the AS/PsA was evaluated by Bath Ankylosing Spondylitis Disease Activity Score (BASDAI), the
 serum C-reactive protein (CRP) and IgA were measured by nephelometry, and erythro...</description>
            <author>Clinical Rheumatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3368893</comments>
            <pubDate>Sun, 14 Mar 2010 12:25:44 +0100</pubDate>
            <guid isPermaLink="false">3368893</guid>        </item>
        <item>
            <title>The Bath Ankylosing Spondylitis Activity and Function Indices (BASDAI and BASFI) and their correlation with main symptoms experienced by patients with spondyloarthritis</title>
            <link>http://www.medworm.com/index.php?rid=3368894&amp;cid=c_1_41_f&amp;fid=33456&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe078500m1v30h5l3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;With the aim of assessing whether the Bath Ankylosing Spondylitis Activity and Function Indices (BASDAI and BASFI) are reliable
 measures of disease activity and function in patients with spondyloarthritides (SpAs), 341 patients with SpA (representing
 ankylosing spondylitis (14.5%), psoriatic arthritis (27.3%), enteropathic arthritis (6.3%), reactive arthritis (4.9%), and
 undifferentiated arthritis (46.5%) were asked to complete the BASDAI and BASFI. They were asked to report what their main
 problems associated with the disease were from a list of seven symptoms: fatigue, neck pain, upper back pain, lower back pain,
 stiffness, joint pain or swelling, and pain with pressure on joints. Correlations between the main symptoms experienced by
 patients with SpAs and the i...</description>
            <author>Clinical Rheumatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3368894</comments>
            <pubDate>Sun, 14 Mar 2010 12:25:43 +0100</pubDate>
            <guid isPermaLink="false">3368894</guid>        </item>
        <item>
            <title>The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis</title>
            <link>http://www.medworm.com/index.php?rid=3368375&amp;cid=c_1_31_f&amp;fid=33316&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm50725282420r39q%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The development of agents that modulate the actions of IL-6 and those of other pro-inflammatory mediators of bone loss may
 provide alternative osteoporosis management strategies for patients with RA than existing general osteoporosis therapies.
 
 
 
 
	Content Type Journal ArticleCategory ReviewDOI 10.1007/s00198-010-1192-7Authors
		C. J. Edwards, Southampton University Hospital Department of Rheumatology Tremona Road Southampton SO16 6YD UKE. Williams, Southampton University Hospital Department of Rheumatology Tremona Road Southampton SO16 6YD UK
	

	
		Journal Osteoporosis InternationalOnline ISSN 1433-2965Print ISSN 0937-941X (Source: Osteoporosis International)</description>
            <author>Osteoporosis International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3368375</comments>
            <pubDate>Sun, 14 Mar 2010 11:30:06 +0100</pubDate>
            <guid isPermaLink="false">3368375</guid>        </item>
        <item>
            <title>Bee stings as therapy? Apitherapy can treat arthritis and more</title>
            <link>http://www.medworm.com/index.php?rid=3365946&amp;cid=c_1_91_f&amp;fid=36976&amp;url=http%3A%2F%2Fwww.NaturalNews.com%2F028370_apitherapy_bee_stings.html</link>
            <description>(NaturalNews) A bee sting is an unpleasant experience that undoubtedly everyone would choose to avoid if given the choice. However a growing number of people are choosing to be stung by bees in an alternative form of illness treatment called apitherapy. Apitherapy contends that bee venom holds therapeutic value in treating serious illness and that it is a viable alternative to dangerous pharmaceutical drugs that often do not work and have harmful side effects.Apitherapy, a traditional folk remedy that has been used in many other countries for centuries, takes advantage of the healing power contained in honeybee venom which helps to alleviate serious conditions like multiple sclerosis, arthritis, and lupus. According to 51-year-old Reyah Carlson of Vermont, a proponent of apitherapy, bee ve...</description>
            <author>NaturalNews.com</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3365946</comments>
            <pubDate>Sun, 14 Mar 2010 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">3365946</guid>        </item>
        <item>
            <title>Knee replacement in elderly patients shown to improve balance</title>
            <link>http://www.medworm.com/index.php?rid=3361789&amp;cid=c_1_58_f&amp;fid=23305&amp;url=http%3A%2F%2Ffeeds.sciencedaily.com%2F%7Er%2Fsciencedaily%2F%7E3%2Fo07szdOylPw%2F100311074117.htm</link>
            <description>Total knee replacement (TKR) successfully relieves pain and improves function in patients with advanced knee arthritis, according to a new study. (Source: ScienceDaily Headlines)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>ScienceDaily Headlines</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3361789</comments>
            <pubDate>Sat, 13 Mar 2010 10:00:00 +0100</pubDate>
            <guid isPermaLink="false">3361789</guid>        </item>
        <item>
            <title>Multiple Benefits To Surgery Reported For Patients With Advanced Osteoarthritis</title>
            <link>http://www.medworm.com/index.php?rid=3359981&amp;cid=c_1_26_f&amp;fid=23292&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2Fb8-iovFqzLc%2F3yRj</link>
            <description>Total knee replacement (TKR) successfully relieves pain and improves function in patients with advanced knee arthritis, according to a study presented at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). The surgery also significantly improves dynamic balance among elderly patients. Impaired balance and increased tendency to fall are common complaints among the elderly suffering from severe osteoarthritis (worn cartilage)... (Source: Health News from Medical News Today)</description>
            <author>Health News from Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3359981</comments>
            <pubDate>Sat, 13 Mar 2010 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">3359981</guid>        </item>
        <item>
            <title>Multiple Benefits To Surgery Reported For Patients With Advanced Osteoarthritis</title>
            <link>http://www.medworm.com/index.php?rid=3360843&amp;cid=c_1_18_f&amp;fid=28415&amp;url=http%3A%2F%2Fmnt.to%2Ff%2F3yRj</link>
            <description>Total knee replacement (TKR) successfully relieves pain and improves function in patients with advanced knee arthritis, according to a study presented at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). The surgery also significantly improves dynamic balance among elderly patients... (Source: Seniors / Aging News From Medical News Today)</description>
            <author>Seniors / Aging News From Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3360843</comments>
            <pubDate>Sat, 13 Mar 2010 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">3360843</guid>        </item>
        <item>
            <title>Etanercept and Venous Thromboembolism: A Case Series</title>
            <link>http://www.medworm.com/index.php?rid=3357270&amp;cid=c_1_41_f&amp;fid=29980&amp;url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F717167%3Fsrc%3Drss</link>
            <description>Three arthritis patients taking Etanercept, an anti-TNF agent, present with deep vein thrombosis (DVT.)  Journal of Medical Case Reports (Source: Medscape Rheumatology Headlines)</description>
            <author>Medscape Rheumatology Headlines</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3357270</comments>
            <pubDate>Fri, 12 Mar 2010 14:51:31 +0100</pubDate>
            <guid isPermaLink="false">3357270</guid>        </item>
        <item>
            <title>MRC Scientists Announce Advance In Understanding Body's Natural Defences</title>
            <link>http://www.medworm.com/index.php?rid=3355403&amp;cid=c_1_3_f&amp;fid=33183&amp;url=http%3A%2F%2Fmnt.to%2Ff%2F3yQf</link>
            <description>Medical Research Council (MRC) scientists at the University of Leicester have made a new advance in understanding how the body fights certain types of cancer and other disease such as Lupus and rheumatoid arthritis.  Dr Melania Capasso, one of the authors of the study, described the findings as being 'very significant'... (Source: Immune System / Vaccines News From Medical News Today)</description>
            <author>Immune System / Vaccines News From Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3355403</comments>
            <pubDate>Fri, 12 Mar 2010 10:00:00 +0100</pubDate>
            <guid isPermaLink="false">3355403</guid>        </item>
        <item>
            <title>CBio Secures Another Clinical Trial Milestone</title>
            <link>http://www.medworm.com/index.php?rid=3355843&amp;cid=c_1_26_f&amp;fid=23292&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2FkTct4_HIXiI%2F3yQ5</link>
            <description>Australian drug development company CBio Limited (ASX: CBZ) announced the achievement of a clinical trial milestone under its option agreement with global pharmaceutical leader Novo Nordisk A/S. The agreement relates to the development of XToll, the potential new-generation drug therapy which could provide safer and more effective treatment of autoimmune diseases such as rheumatoid arthritis (RA). The clinical trial milestone was triggered by the recruitment of the 75th patient into the current 150 patient phase II clinical trial... (Source: Health News from Medical News Today)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Health News from Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3355843</comments>
            <pubDate>Fri, 12 Mar 2010 10:00:00 +0100</pubDate>
            <guid isPermaLink="false">3355843</guid>        </item>
        <item>
            <title>MRC Scientists Announce Advance In Understanding Body's Natural Defences</title>
            <link>http://www.medworm.com/index.php?rid=3355849&amp;cid=c_1_26_f&amp;fid=23292&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2FVttlzFmyIWQ%2F3yQf</link>
            <description>Medical Research Council (MRC) scientists at the University of Leicester have made a new advance in understanding how the body fights certain types of cancer and other disease such as Lupus and rheumatoid arthritis.  Dr Melania Capasso, one of the authors of the study, described the findings as being 'very significant'. &quot;We showed that a newly discovered protein, HVCN1, regulates antibody production through modulation of intracellular oxidation. In the absence of HVCN1, the immune response is blunted... (Source: Health News from Medical News Today)</description>
            <author>Health News from Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3355849</comments>
            <pubDate>Fri, 12 Mar 2010 10:00:00 +0100</pubDate>
            <guid isPermaLink="false">3355849</guid>        </item>
        <item>
            <title>CBio Secures Another Clinical Trial Milestone</title>
            <link>http://www.medworm.com/index.php?rid=3356837&amp;cid=c_1_34_f&amp;fid=22568&amp;url=http%3A%2F%2Fmnt.to%2Ff%2F3yQ5</link>
            <description>Australian drug development company CBio Limited (ASX: CBZ) announced the achievement of a clinical trial milestone under its option agreement with global pharmaceutical leader Novo Nordisk A/S. The agreement relates to the development of XToll, the potential new-generation drug therapy which could provide safer and more effective treatment of autoimmune diseases such as rheumatoid arthritis (RA)... (Source: Pharma Industry News From Medical News Today)</description>
            <author>Pharma Industry News From Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3356837</comments>
            <pubDate>Fri, 12 Mar 2010 10:00:00 +0100</pubDate>
            <guid isPermaLink="false">3356837</guid>        </item>
        <item>
            <title>Knee Replacement In Elderly Patients Shown To Improve Balance</title>
            <link>http://www.medworm.com/index.php?rid=3355362&amp;cid=c_1_26_f&amp;fid=23292&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2FQbV2bWh-1-4%2F3yPK</link>
            <description>Total knee replacement (TKR) successfully relieves pain and improves function in patients with advanced knee arthritis, according to a study presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). The surgery also significantly improves dynamic balance among elderly patients. Impaired balance and increased tendency to fall are common complaints among the elderly suffering from severe osteoarthritis (worn cartilage)... (Source: Health News from Medical News Today)</description>
            <author>Health News from Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3355362</comments>
            <pubDate>Fri, 12 Mar 2010 09:00:00 +0100</pubDate>
            <guid isPermaLink="false">3355362</guid>        </item>
        <item>
            <title>Knee Replacement In Elderly Patients Shown To Improve Balance</title>
            <link>http://www.medworm.com/index.php?rid=3356081&amp;cid=c_1_18_f&amp;fid=28415&amp;url=http%3A%2F%2Fmnt.to%2Ff%2F3yPK</link>
            <description>Total knee replacement (TKR) successfully relieves pain and improves function in patients with advanced knee arthritis, according to a study presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). The surgery also significantly improves dynamic balance among elderly patients... (Source: Seniors / Aging News From Medical News Today)</description>
            <author>Seniors / Aging News From Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3356081</comments>
            <pubDate>Fri, 12 Mar 2010 09:00:00 +0100</pubDate>
            <guid isPermaLink="false">3356081</guid>        </item>
        <item>
            <title>Health Tip: IBD May Contribute to Other Health Problems</title>
            <link>http://www.medworm.com/index.php?rid=3361473&amp;cid=c_1_41_f&amp;fid=29977&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D114319%26k%3DArthritis_General</link>
            <description>Title: Health Tip: IBD May Contribute to Other Health ProblemsCategory: Health NewsCreated: 3/11/2010 10:10:00 AMLast Editorial Review: 3/12/2010 (Source: MedicineNet Arthritis General)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>MedicineNet Arthritis General</author>
            <type>consumer</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3361473</comments>
            <pubDate>Fri, 12 Mar 2010 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">3361473</guid>        </item>
        <item>
            <title>New Knee May Improve Balance</title>
            <link>http://www.medworm.com/index.php?rid=3361474&amp;cid=c_1_41_f&amp;fid=29977&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D114320%26k%3DArthritis_General</link>
            <description>Title: New Knee May Improve BalanceCategory: Health NewsCreated: 3/11/2010 10:10:00 AMLast Editorial Review: 3/12/2010 (Source: MedicineNet Arthritis General)</description>
            <author>MedicineNet Arthritis General</author>
            <type>consumer</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3361474</comments>
            <pubDate>Fri, 12 Mar 2010 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">3361474</guid>        </item>
        <item>
            <title>Long-Term Use of Osteoporosis Drugs Linked to Fractures</title>
            <link>http://www.medworm.com/index.php?rid=3361475&amp;cid=c_1_41_f&amp;fid=29977&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D114341%26k%3DArthritis_General</link>
            <description>Title: Long-Term Use of Osteoporosis Drugs Linked to FracturesCategory: Health NewsCreated: 3/11/2010 2:10:00 PMLast Editorial Review: 3/12/2010 (Source: MedicineNet Arthritis General)</description>
            <author>MedicineNet Arthritis General</author>
            <type>consumer</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3361475</comments>
            <pubDate>Fri, 12 Mar 2010 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">3361475</guid>        </item>
        <item>
            <title>Differences between the Health Assessment Questionnaire Disability Index (HAQ-DI) and the modified HAQ (mHAQ) score before and after infliximab treatment in patients with rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3363456&amp;cid=c_1_41_f&amp;fid=33329&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv27887367w816273%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We conducted a 1-year prospective study to clarify differences between the Health Assessment Questionnaire disability index
 (HAQ-DI) and the modified HAQ (mHAQ) score among rheumatoid arthritis (RA) patients treated with infliximab. A total of 87
 patients were scheduled to receive infliximab infusion at a dose of 3&amp;nbsp;mg/kg at weeks 0, 2, and 6, and every 8&amp;nbsp;weeks thereafter
 for 54&amp;nbsp;weeks; all patients received a full examination at each infusion appointment. The 28-joint disease activity score (DAS28)
 and functional capability of each patient was assessed at each visit, using the HAQ-DI and the mHAQ score. A strong correlation
 was observed between the HAQ-DI and the mHAQ score at baseline (r&amp;nbsp;=&amp;nbsp;0.892). Over the course of the treatment, the mean ...</description>
            <author>Modern Rheumatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3363456</comments>
            <pubDate>Fri, 12 Mar 2010 06:51:27 +0100</pubDate>
            <guid isPermaLink="false">3363456</guid>        </item>
        <item>
            <title>Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study</title>
            <link>http://www.medworm.com/index.php?rid=3357263&amp;cid=c_1_41_f&amp;fid=29968&amp;url=http%3A%2F%2Farthritis-research.com%2Fcontent%2F12%2F2%2FR42</link>
            <description>IntroductionWork disability is a major consequence of rheumatoid arthritis (RA), associated not only with traditional disease activity variables, but also more significantly with demographic, functional, occupational, and societal variables. Recent reports suggest that the use of biologic agents offers potential for reduced work disability rates, but the conclusions are based on surrogate disease activity measures derived from studies primarily from Western countries.
Methods:
The Quantitative Standard Monitoring of Patients with RA (QUEST-RA) multinational database of 8,039 patients in 86 sites in 32 countries, 16 with high gross domestic product (GDP) (&gt;24K U.S dollars (USD) per capita) and 16 low-GDP countries ( (Source: Arthritis Research and Therapy)</description>
            <author>Arthritis Research and Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3357263</comments>
            <pubDate>Fri, 12 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3357263</guid>        </item>
        <item>
            <title>DNA microarray analysis of rheumatoid arthritis (RA) susceptibility genes identified by genome-wide association studies (GWAS)</title>
            <link>http://www.medworm.com/index.php?rid=3357264&amp;cid=c_1_41_f&amp;fid=29968&amp;url=http%3A%2F%2Farthritis-research.com%2Fcontent%2F12%2F2%2F401</link>
            <description>This study aims to clarify whether DNA microarray analysis and GWASs produce comparable results with respect to RA susceptibility genes. (Source: Arthritis Research and Therapy)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Get the very latest Swine Flu news via the MedWorm &lt;b&gt;&lt;a href=&quot;http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&amp;t=Swine+Flu&amp;f=infectiousdiseases&amp;r=Any&amp;o=d&quot; target =&quot;_self&quot;&gt;Swine Flu RSS news feed&lt;/a&gt;&lt;/b&gt; -  updated hourly from thousands of authoritative health and news sources.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Arthritis Research and Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3357264</comments>
            <pubDate>Fri, 12 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3357264</guid>        </item>
        <item>
            <title>Preferences for health outcomes associated with Group A Streptococcal disease and vaccination</title>
            <link>http://www.medworm.com/index.php?rid=3357507&amp;cid=c_1_46_f&amp;fid=34066&amp;url=http%3A%2F%2Fwww.hqlo.com%2Fcontent%2F8%2F1%2F28</link>
            <description>Conclusions:
Parents strongly prefer to prevent GAS disease in children compared to vaccine adverse events. However, WTP/QALY thresholds were higher for the prevention of vaccine adverse events. Regret for errors of commission vs. omission may differ and should be considered by vaccine policymakers. (Source: Health and Quality of Life Outcomes)</description>
            <author>Health and Quality of Life Outcomes</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3357507</comments>
            <pubDate>Fri, 12 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3357507</guid>        </item>
        <item>
            <title>Tumor Necrosis Factor Alpha Converting Enzyme: An Encouraging Target for Various Inflammatory Disorders</title>
            <link>http://www.medworm.com/index.php?rid=3358291&amp;cid=c_1_62_f&amp;fid=32060&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1747-0285.2010.00950.x</link>
            <description>Tumor necrosis factor alpha is one of the most common pro-inflammatory cytokines responsible for various inflammatory disorders. It plays an important role in the origin and progression of rheumatoid arthritis and also in other autoimmune disease conditions. Some anti-tumor necrosis factor alpha antibodies like Enbrel®, Humira® and Remicade® have been successfully used in these disease conditions as antagonists of tumor necrosis factor alpha. Inhibition of generation of active form of tumor necrosis factor alpha is a promising therapy for various inflammatory disorders. Therefore, the inhibition of an enzyme (tumor necrosis factor alpha converting enzyme), which is responsible for processing inactive form of tumor necrosis factor alpha into its active soluble form, is an encouraging tar...</description>
            <author>Chemical Biology and Drug Design</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3358291</comments>
            <pubDate>Fri, 12 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3358291</guid>        </item>
        <item>
            <title>SSRIs Show Anti-Inflammatory Benefit in RA Models</title>
            <link>http://www.medworm.com/index.php?rid=3360975&amp;cid=c_1_22_f&amp;fid=38164&amp;url=http%3A%2F%2Fwww.modernmedicine.com%2Fmodernmedicine%2FModern%2BMedicine%2BNow%2FSSRIs-Show-Anti-Inflammatory-Benefit-in-RA-Models%2FArticleNewsFeed%2FArticle%2Fdetail%2F661230%3Fref%3D25</link>
            <description>Fluoxetine and citalopram show an anti-inflammatory benefit in rheumatoid arthritis in laboratory
  experiments, with findings pointing toward endosomal Toll-like receptors as a target for therapy in the disease,
  according to research published in the March issue of Arthritis &amp;amp; Rheumatism. (Source: Modern Medicine)</description>
            <author>Modern Medicine</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3360975</comments>
            <pubDate>Fri, 12 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3360975</guid>        </item>
        <item>
            <title>Lipoprotein Autoantibodies Higher in More Active Lupus</title>
            <link>http://www.medworm.com/index.php?rid=3360983&amp;cid=c_1_22_f&amp;fid=38164&amp;url=http%3A%2F%2Fwww.modernmedicine.com%2Fmodernmedicine%2FPathology%2FLipoprotein-Autoantibodies-Higher-in-More-Active-L%2FArticleNewsFeed%2FArticle%2Fdetail%2F661153%3Fref%3D25</link>
            <description>In patients with systemic lupus erythematosus, those with persistently high disease activity have
  higher levels of anti-apolipoprotein A-I and anti-high-density lipoprotein than those with low disease activity,
  according to research published in the March issue of Arthritis &amp;amp; Rheumatism. (Source: Modern Medicine)</description>
            <author>Modern Medicine</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3360983</comments>
            <pubDate>Fri, 12 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3360983</guid>        </item>
    </channel>
</rss>
